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For centuries, researchers have attempted to devise 
the ideal .parenteral nutritional product readily amenable to 
physiological requirements. Hyperalimentation, intravenous 
alimentation, parenteral alimentation, parenteral feeding, 
and total parenteral nutrition are synonyms which refer to 
a method of complete intravenous nutrition reserved for 
patients demonstrating negative nitrogen balance. 
--------- ---
Substances such as wine, h.oney, and oils found common 
employment in intravenous nutrition from the seventeenth to 
nineteenth century, prior to the development and refinement 
of lipid emulsions (1). The lipid preparations possess 
greater nutritional energy, yielding 9 calories/Gm as com-
pared to approximately 4 calories/Gm from dextrose (2). .HovJ-
ever, limiteo. success was attained in this country in 1935 
with parenterally administered lipid emulsions (3) .. The prob-· 
lem of volume overload, a common occurrence when utilizing 
dextrose vehicles, was reduced. The employment of fatty acid 
preparations rapidly revealed numerous unpleasant·side effects 
related to excessive fat metabolism (3). Patients complained 
of nauGea, vomiting, chills, and symptoms of what became 
know"Il as the "colloid reaction". The latter response was 
manifested by back pain, flushing, cyanosis, apprehension, 
1 
2 
dyspnea, and was occasionally accompanied by hemorirhaging .. ·. 
tendencies, fever, epigastric pain, jaundice, thrombocytopenia, 
and lipid deposition inthe Kiipfer·cells (3-5). Lipid emul-
sions were obviously. not .the panacea of parenteral feeding. 
Parenteral administration of amino acids by Elman (6), 
in 1938, provided encouraging results. However, the initial 
breakthrough in total parenteral feeding was accomplished by 
Dudrick, et al. (7,8) in 1966. This proced.ure was soon modi-
fied for clinical use after demonstration of normal weight 
gain and positive nitrogen balance in experimental animals 
(9-11). Dudrick's formulation consisted of a hyperosmolar 
infusate containing protein hydrolysates, dextrose, electro-
lytes, vitamins and minerals. administered via an indv!elling 
catheter positioned. in the subclavian vein (1,4-,9,12). 
Protein Hydrolysate Injection, U.S.P., remained the 
principle source of nutritional nitrogen until just a fe'iv 
years ago. This product ,.,as prepared initially from hydro-
lyzed casein and subsequently from beef blood fibrin. HovT-
ever, the hydrolysates required the addition of cystine and 
tryptophan after processing for pyrogens (3). Unfortunately, 
they contained non-metabolizable polypeptides, which con-
tributed to significant water and sodium retention, positive 
potassium balance, zero nitrogen balance, and ammoniuria (12). 
Those cases of hypersensitivity to protein hydrolysates c.ited 
were postulated to be related to the.polypeptide content (15, 
16)~ 
The inherent disadvantages of protein hydrolysates 
;- -'-'.=--=-=--'-.-'--=----
prompted·researchers to undertake an investigation employing 
crystalline or synthetic amino acids as a nutritional source. 
It was determined that these preparations would offer purity, 
lack of non-essential amino acids,· flexibility of individual 
component concentration, reduction of BUN levels due to urea 
utilization in protein synthesis (1B,37), and decreased. 
instances of anaphylactoid reactions (3). Flexibility of 
ingredient concentrationwill permit future amino acid·solu-
tion formulations to correspond better to true physiological 
plasma concentrations, \vhich is a concern expressed by Stegink, 
et al. (18). Unfortunately, metabolism of DL amino acid. com-
binations was found incomplete (13). These preparations 
appeared to promot~ increased urinary urea levels accompanied 
with negative nitrogen, potassium and sodium balance (12). On 
the other hand., synthetic L amino acid formulations were fo1md 
superior, especially vvhen administered to patients v1ith acute 
renal failure (15-17). 
Parenteral alimentation has been indicated for patients 
exhibiting a catabolic state resulting from decreased caloric 
intake or increased caloric requirement (19). As catalysis 
progresses, cachectic patients' ability to recover and ward-
off further infection is reduced (3,10). 
Clinical indications for hyperalimentation include (20): 
1. Patients "v'Jho cannot eat: 
esophageal carcinoma 
gastric carcinoma 
obstructive peptic ulcer 
paralytic ileus 
2.. Patients \'Jho should avoid eating: 







3. Patients who cannot consume sufficient foodstuffs: 
multiple injury affliction 
major full thickness burns 
ulcerative colitis 
short bowel syndrome 
malabsorption syndrome 
4. Patients who refuse to eat sufficient amounts: 
----------------po-st- -operat-ive- --geriactric s-
anorexia nervosa, etc. 
·5. Infants with congenital anomalies or chronic· 
diarrhea 
Many complications evobring with the implementation· 
of hyperalimentation are possibly due to technique rather than 
the procedure. There have been reports of thrombosis of major 
Yessels (i), sepsis (!+,11,22--26,35,45), extravasation (22), 
hyperglycemia associated \'lith osmotic diuresis, dehydration, 
and hyperosmolar state (14,15,22 ,2'7-29), volume overl0ad and 
heart failure (1,22), metabolic acidosis (22,30-32), abnormal 
plasma aminograms (22), bone abnormalities (1,22,33,34) hypo-
phosphatemia (22,28,36,37), liver necrosis (1,22), vitamin and 
trace mineral deficiencies (1,22,3L~,36,37), hypersensitivity 
to protein hydrolysate (14,15), possible cholestasis (38), 
hyperammonemia and hyperaminoacidemia (30,39,76), glucosuria 
(14-), occurrence of essential fatty acid deficiency (40), and 
iatrogenic hypercalcemia (1+1). 
Complete parenteral feeding necessitates a balanced 
infusate containing protein, carbohydrate, electrolytes, 
vitamins, and minerals adapted to patient requisites (1,1+,9-12). 
5 
To mai:trliain positive nitrogen balance, approximately 150 
non-protein calories are required for each·Gm of protein. 
nitrogen (1,19,43). Proper correlation of caloric intake 
with protein will induce the most efficient anabolic.state 
(45), as ·decreased intake of non-protein calories may promote 
protein catabolism to fulfill energy requirements resulting 
in decreased nitrogen balance (42). Each 100 Gms of protein 
will yield approximately 14 to 16 Gms of nitrogen (19,44). 
]•or the normal adult at optimum metabolic ·efficiency, Munro 
stated that daily body requirements could be estimated 
probably not to exceed 0.45 Gms nitrogen/Kg body weight (46). 
Severely burned patients may demand up to 10 times this 
q~antity (3~43). The remaining sl~pplemental additives and 
concentrations utilized depend upon patient need determined 
through regular serum level analysis (4,10,47).. Consequently, 
discussion concerning these additives, rationale for inclusion, 
therapeutic levels utilized, and compatibility problems 
encountered, will serve as the criteria in establishing the 
guidelines for the investigation of compatibility and stability 
of 8% Amino Acids Solutiona (see Table 1) in the presence of 
supplemental admixtures. 
The requirement for mono-valent electrolytes has, been 
well documented (4,5,11,12,18,19,32,L~5,48-58). Sodium ion is 
required in the development of membrane potentials and the 
· activation of the cellular membrane at the onset of action 
a- Trademark, Cutter Laboratories, Inc., Berkeley, Ca. 
___ 
potentials (59). In addition, this cation influences the 
tonicity of body fluids and controls the osmotic pressure 
6 
of the extracellular fluid (60) •. · \Dudrick, ~ §;1. (8,10) 
have suggested 125 to 150 mEq of sodium supple.mentation 
over a 24hour period to assist in promoting ·positive nitro--
gen balance. 
Potassium has been reported to render significant 
roles in the conduction of nerve impulses, muscular contrac-
tion, enzymatic reactions, and cell membrane potentials (61). 
The dally patient regimen has required 75 to 120 mEq in main-
taining physiologic function and promoting positive nitroge!.l 
balance (8,10). 
Complete intravenous alimentation will necessarily 
.dmta5.J. the actmixture o.f various poly-valent electrolytes in 
accordance 1.vith patient serum levels (1,3-5,10-12,18,19,45, 
47-57,62). Calcium does play an important role in the physio-
logical body functions being an ion essential for the skeletal 
system, regulation of cell membrane permiability and resulting 
action potentials, muscle contraction, release of ADH from the 
neurohypophysis, release of catecholamines from the adrenal 
medulla., blood coagulation, normal cardiac function, and 
maintenance of the continuum (63). Therapeutic calcium requi-
sites cited are dependent upon the age and affliction of the 
pa·tient. .Neonates and infants demand higher levels due to 
their elevated grovrth rate. Some authorities suggest 0 .. 5 to 
4 mEq/Kg/2~- hours (18,48,49,55,56), others 2 to 25 mEq/L of 
infusate (12,19,50,51,53). Adult concentrations may vary 
7 
Ingredients of 8% Amino Acids. ~Solution/100 ml 
*Essential amino acids 
Aminoacetic Acid, N.F ••••••• 
L-Arginine • • • • • • • • • • • • 
L-Aspartic Acid • • • • • • • • • 
L-Glutamic Acid • • .. • • • • • • • 
I.~-Hi-st-i-d-i-n-e--.-----.--.---.--.---.---- • • -. • ---. 
L-Isoleucine* • • • • • • • • • • 
L-Leucine* • • • • • • • • • • • • 
L-Lysine HCl* •••••••••• 
L-Methionine* • • • • • • • • • • 
L-Phenylalanine* • • • • • • • • • 
L-Proline • • • • • • • • • • • 
L-Threonine* .. • • • • • • • • • • 
L-Tryptophan* • • ••••••• 














• Sodium Ac et ate 'I'rihydrat e , N. ]'. 
Potassium Aceta·t::-;, N .F. . o • • • • 
:Potassium Chloride? U.,S.P., ...... 
Magnesium Chlorid.e Hexahydrate • • 
Potassium fvietabisulfite ...... 






• • • • 
• • • • 
• • • • 
• • • • 
. - . -. . 
• • • • 
• • • • 
• c • • 
• • • • 
. . . -· 
• • • • 
• • • • 
• • • 0 
• • • • 
• • • • 
• • • • 
. . .. 
• • c: • 
• • • • 
• • • • 
Electrolytes Provided By 
• • 3.387 grams 
• • 0.749 grams 
• 
• 0.400 grams 















-- • 0. 237 -grams- -- __ 
• 0.493 grams 
• 0. 3L~7 grams 
• 0.667 grams 
•. 0. 427 grams 
o 0. L~OO g-.cams 
• 0 .. 10'7 grams 
• 0.,160 grams 
• 0.080 grams 
• 0.253 grams 
• 0.388 grams 
• 0.211 grams 
• 0 .. 056 grams 
• 0.061 
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from 2 to 20 mEq/L (11,12,18,32,47,51,53,54,56-58). Calc$um 
gluconate injection appears to be the preparation of choice 
as the supplemental adjunct for calcium deficiencies (11,12, 
45,47,51,53,57). However, problems \vith precipitation have 
been noted 'I:Jith its addition to protein hydrolysate alimenta-
tion solution (64,65), and the presence of sulfates, phosphates, 
and alcohol (66) • 
. Phosphate has an essential function in bone metabolism, 
transformation and production of high energy compounds required 
in the biochemical path1.vays (37 ,51), plasma buffering and renal 
excretion of hydrogen ion (67). Routine serum level deter-
minationo will dictate patient need for supplementation. 
I~fants may require 2 to ll.J. mEq/Kg/24 hours (18,45,'+8,55,56) 
or 3.9 to 15 mEq/JJ (19,1+7,52,5LJ·). Upper limits as high as 
25 mEq/650 ml of ;i.nfusate have been employed (12,53).. Supple-
mental phosphate for adult hyperalimentation solutions may 
range from 4 to 27 mEq/L (11,12,18,32,47,50,51,53,56,58). 
However, the addition of phosphate to parenteral alimentation 
solutions may lead to precipitation in combination with cal-
cium gluconate (66). 
Magnesium is required for various intermediate meta-
bolic path~Jays for the production of energy from glucose for 
protein synthesis (18,37), activation of the oxidative phos-
phorylation enzyme systems (51), and membrane ATPase (63). 
Daily observance of serum levels serve as a guidE-) in main-
taining the physiological demand. Pediatric concentrations 
utilized have varied from 0.5 to 2.0 mEq/Kg/21~- hours (19,48, 
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49,55,56), 1.2 to 1.8 mEq/IJ (50,54,56), and 10 mEq/650 ml 
of infusate (53). Adult levels have varied from 2 to 8 mEq/L 
(11,12,32,LJ.5,51,53,57 ,62). Magnesium sulfate injection appears 
to be the· soluble salt form used most often (5,11,12,32,45,51, 
53,57,62). As such, precipitation in the presence of calcium 
gluconate (66), protein hydrolysates (65), alcohol, and phos-
phates (68) has been reported. The manufacturer of 8% Amino 
·Acids Solution elected to add magnesium chloride as the 
hexahydrate to avoid the possibility of precipitation, 
apparently linked with the sulfate salt form. 
Trace elements may be required upon detection of 
deficiency states. Recent literature describes copper 
deficits associated with long term alimentation (34,69,70). 
,,Such complications must be considered when administering 
protein sources lacking trace elementso The employment of 
2 to 3 mg of iron dextran is useful in relieving anemias 
(4,11,18,47) •. Supplementation of other trace minerals such 
as zinc, cobalt, manganese, and iodine has been implemented 
through intermittant administration of plasma or 1r1hole blood 
when the necessity arises (1,4,8) .. 
Physiological demand forvitamins appears undisputed.' 
Patai remarked that ". • • B-complex vitamins all containing. 
nitrogen appear to function, in a more or less understood 
way, to act as cofactors for enzyme-catalyzed metabolic 
reactions~ •• " (73). Greene (78) has implied that: 
1. Vitamins are intimately involved in metabolism 
of carbohydrates, protein, and fat. As a result, 
they definitely possess a role in parenteral 
nutrition. 
2. Due to rapidly developing deficiencies in 
patients considered for parenteral nutrition~ 
their inclusion is mandatory. 
3. The requirement for parenteral vmter soluble 
vitamins appears magnified as compared to 
oral demands due to renal excretion. 
4. Whenever fat soluble vitamins are employed; 
care should be exercised to avoid overdosing 
the patient. 
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Vitamin combinations containing fat and water soluble 
componen.tsa have received the greatest utilization (1,4,5,11, 
18,45,50-52,57,58,62). Employment of B-complex with ascorbic 
acidb has also been mentioned (18,58,71). Infant requirements 
for fat and water soluble vitamins have been fulfilled with 
1-10. ml of NVI (1,18,19,L~5,52,72). Adult requisites were met 
with 5-10 ml of MVI (L~,5,11,18,50,51,57,58,62), 10 ml of 
Solu B Forte (58,71), and 2 ml of Berocca C (18). Refer to 
Table 2 for vitamin content., 
Folic acid participates in the conversion of certain 
amino a.cids to intermediates in production of deoxyribonucleic 
acid (7~-)~ Consequently, this vitamin remains essential for 
normal grov~h and maturation of erythrocytes (74). Therapeutic 
supplementation may vary from 5 micrograms to 10 mg (1,4,11,32~ 
45,LV?,50,51,57). The addition of folic acid to nutritional 
formulashas presented compatibility problems .. Burke stated 
precipitation may occur in the presence o.f calcium salts (79). 
a- I1VI, u.s.v. Pharmaceutical Corp., Tuckahoe, N.Y. 
b - Solu B Forte, The Upjohn Co., Kalamazoo, Mich.; Berocca 
C, Roche I1aboratories~ Div~, Hoffmann-La Roche, Nutley, 
N •. J • 
Table 2 
Vitamin Content of MVI 10 ml Ampul and 
MVI Concentrate 5 ml Multidose Vial 
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Vitamin A • • • • • • • • • • • • • • • 
Vitamin D • • •. ., • • • • • • ••• ~ • 
Vitamin E (DL alpha Tocopheryl 
10,000 u.s.P. units 
4,000 U.S.P. units 
acetate) • • . • • • • • • • • • • • 5 International 
Thiamine_H_QL_~.--• __ • .. • • _.· __ • _. • .. • • • • _ • • __ • _. 
Riboflavin • • • • • • • • .. • • • • • • • • . • • • 
Niacinamide • • • • • • • • • • • • • • • • • • 
Pyridoxine HCL • • • • • • • • • • • • • • • • • • 
Dexpanthenol • • • • • • • • • • • • • • • • • • • 
Ascorbic Acid • • • • • • • • • • • • • • • • • • 
Vitamin Content of Solu B Forte 10 ml 
Thiamine HCL • .. • • • • • • • • • • • • • • • • • Riboflavin • • • • • • • • • • • • .. • • • • • • • Pyridoxine HCL • • • • • .. • • • • • • . • • • • • 
units 
50 mg 








Niacinamide • • • • • • • • • • • • • • • • • • • 1,250 mg Sodium Pantothenate • • .. • • • • .. • • • • • • .. Ascorbic Acid • • • • • • • • ~ • • • • • • • • • 
Vitamin Content of Berocca C 2 ml Ampul 
Thiamine HCL • e • ., • • ., • • .. • • • • • • • • • 
Riboflavin • • • • • • • • • • • • • • • • • • • • 
Niacinamide • • • • • • • ~ • • e • • • • c • ., • 
D-panthenol • • • • • • • • • • • • - • • • • • • • 
Pyridoxine HOL ., .. • • • ~- • .. .. • • • • • • • • • 
Ascorbic Acid • • • • • • • • • • • • • • • • • • 











Exposure to excessive light (80,81}, riboflavin (81), and 
oxidizing or reducing agerits such as ascorbic acid nave been 
implicated in the decomposition o:r· folic acid (80,81). 
Cyanocobalamin is referred-to as the "Maturation 
Factor" (76). As such,· Guyton contends it ". • • is· an 
essential nutrient for all cells of. the body, and grmvth 
of tissues in general is greatly depressed \vhen this vitamin 
is lacking." (76). Clinicians continue to employ 1 to 1,000 
micrograms of cyanocobalamin injection to fulfill the physio-
logical· requirements during total parenteral nutrition (1,5, 
11,12,32,45,47,50,51,57,58,71). However, inclusion of 
cyanocobalamin in hyperalimentation solutions has been ques-
tioned. Deterioration in the presence of ascorbic acid (79, 
82), vitamin K (79), and elevated levels of dextrose (79) has 
been reported. 
Periodic administration of phytonadione has prevented 
acute episodes of hypoprothrombinemia associated v.rith neonates 
and patients exhibiting deranged gastrointestinal function or 
flora (1). Therapeutic regimens again may vary from 5 micro-
grams to 10 mg (1,18,32,45,47,50,51,57). Phytonadione readily 
decomposes in the presence of light (80-82). There may also 
be inactivation in combination with cyanocobalamin and ascorbic 
acio. (64, 79). 
Hyperglycemic states may be experienced with the onset 
of hyperalimentation infusion. Attempts to control this unde-
sirable complication, especially for .diabetic patients, ·have 
been undertaken with concomitant administration of insulin 
13 
injection (5,11,15). \Vyrich, et al. (15), employed C1initesta 
--
determinations ot glucosuria as criteria for insulin supple-
mentation. Fifteen units are administered for a +4 urine, 
10 units for a +3 urine, and none·«for lower levels of gluco-
suria. Regulation of infusion rates remains the best preven-
tative control measure against hyperglycemic crisis. Serum 
blood sugar levels above 500 mg 96 should not be permitted(15) .. 
Prolongedperiods o.fhyperglycemia predispose patients to 
complications of non-keto acidotic hyperosmotic coma (14,15, 
22,27-29). 
Burke has reported that some investigators indieateQ. 
a 23-27% loss of insulin to glass and tubing adsorption (79). 
Ho\vever, Abel, et al. (83) disclosed insulin adsorption, as 
determined by radioimmun.oassay techniques, appears about 2%. 
The results of a radio-assay analysis conducted by Weisenfeld, 
et 2-.:l• (84) appears to coincide \'lith data mentioned by Burke 
(79). 
Clinicians continue to make inquiries concerning the 
admixture of selected antibiotics to hyperalimentation solu-
tions. Hyman, et al~ (45), incorporated 100,000 units of 
potassium penicillin G into alimentation solutions for pre-
vention of septicemias associated with bacterial contamination. 
Inherent complications arise with such admixtures.. The com-
patibility o.f antibiotic salt forms and the role of pH changes 
have a great influence upon the feasibility of these 
a - Clinitest, Ames Co., Inc .. , Elkhart·, Ind. 
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combinations (77,85). 
Utilization of the purest source.of protein nitrogen 
appears advantageous. This recent literature survey pertained 
primarily to ingredients commonly admixed to protein hydro-
lysates or modified fibrin hydrolysates. The compatibility. 
and· stability of synthetic L-amina acids solutions in com-
bination with customary additives have not been investigated 
except for an electrolyte compatibility study by Kaminski, 
et al. (86) on FreAmine 8.5%a. 
·Incompatibilities are frequently classified as physi-
cal, chemical, and therapeutic. Physical incompatibilities 
are reported as visual manifestations of chemical interaction, 
· i.~ e., precipitation, pH alteratioD:, color change~ or evolution 
of gas (85). Chemical incompatibilities occur without visual 
demonstration and can produce undesirable complications (85). 
Therapeutic interactions are manifestations of directly 
opposed pharmacologic action of two or more simultaneously 
administered medications. This type of incompatibility will 
not be considered in this discussion. 
The 896 Amino Acids Solution is presently classified 
as an investigational product. Consequently, information 
regarding its compatibility and stability \vith commonly 
utilized additives is relatively non-existent. The present 
study was designed to observe a solution of amino acids in 
combination with v·arious concentrations of previously described 
a - Trademark, McGaw Laboratories, Glendale, Ca. 
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.adjuncts for evidence of physical compatibility. ·The 
compatibility data resulting from that segment of the study 
were thenutilized as a guideline in the determination of 
chemical compatibility employing instrumental analysis. 
Initially, u.v. spectroscopy was employed for the_ 
determination of chemical compatibility and stability of 8% 
Amino Acids Solution in those admixtures determined to be 
physically compatible. Those combinations ascertained as 
compatible through U. V. spectroscopy \'Jere subjected to 
further examination by thin layer chromatography. Finally, 
those antibiotic/amino acids mixtures found physically com-
patible \llere subjected to microbiological assay for the 




In. order to simulate clinical conditions, the 
compatibility to the amino acids/dextrose solution admix-
tures \'las determined under conditions of normal lighting 
and at room temperature. Prior to the addition of the 
various additives, the 8% ~nino Acids Solution was mixed 
with equal portions of 50% dextrose in watera to form the 
basic hyperalimentation solution. Aliquots of that mixture 
s.~rved as the base to which other _ingredients were added, 
to yield final concentrations as indicated. 
£11-;y:sical Cogp_at];.bilit;y Study 
To determine the physical compatibility characteris-
tics of the basic amino acids/dextrose hyperalimentation 
solution} various concentrations of the follo·wing additives 
were added to the stock mixture. 
Electrolytes b 
Potassium Phosphate Concentrate 
Calcium Gluconate lO%C 
Magnesium Sulfate 10%d 
a - 509G Dextrose Injection, U.S.P., Cutter Labs. 5 Inc., 
Berkeley, Ca. 
b -~ McGaw Laboratories, Glendale, Ca~ 
c- Calcium Gluconate Injection, U.S.,P., 10%, Pasadena 
Hesearch Laboratories, Pasadena, Ca. 
d- Magnesium Sulfate Injection, U.S .. P., 10%, Eli Lilly 
and Co., Indianapolis, Ind. 
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Vitamins 
(alone and ·with physically compatible 
concentrations of electrolytes only) 
MVI Conc€mtrat e 









------ ----------(aJ:orre-,-w±th-electrolytes, and with electro...; 






Each series of admixtures, examined for physical incom-
P.<?ttibility, was performed utilizing duplicate 25 ml samples of' 
the stoek sol uti on~ As applicable, depe:nd.ing upon the number 
a- Folic Acid Injection, Lederle Laboratories, Div., American 
Cyanamid Co., Pearl River, N. Ye 
b- Cyanocobalamin Injection, U.S.P., E8 R. Squibb and Sons, 
Div .. , Olin f-'lathieson Chemical Corp., Nm·l York, N. Y. 
c- Phytonadione, U.S.P., Merck Sharp and Dohme, Div., Merck 
& Co., \'lest Point, Pa. 
d- Insulin Injection, UoS.P., Eli Lilly & Co., Indianapolis, 
Ind. 
e - Sodium A..mpicillin for Injection, Bristol Laboratories, 
Div.~ Bristol Myers Co., Syracuse, N.Y. 
f- Kanamycin Sulfate Injection, U.S.Po, Bristol Laboratories~ 
Div., Bristol Myers Co., Syracuse, N. Y. 
g- Sterile Sodium Cephalothin, U.S.Pe, Eli Lilly & Co., 
Indianapolis, Ind. 
h- Gentamicin Sulfate, U.SoP., Schering Corp., Bloomfield, 
N .. J. 
of additives, the following order of.mixing was used 
throughout this study, including physical, chemical, TLC, 









biotic was added after the MVI or Solu B Forte. 
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The resulting admixtures, except where indicated, 
were examined at 1, 4-, 8, and 24 hour intervals, against 
black and \vhite backgrouno.s for evidence of physical change. 
A. Corning pH I•leter I-1odel ?a was usea. to take readings at 1 
and 24· hours after admixture, except i'There other\vise indicated. 
Those samples failing to demonstrate physical change '"ere then 
exam:i.ned for chemical compatibility. 
9P.eE.J.i9..Q.l_Q..Q!gpat~biltty_Stud_;z 
u. V • .Sr?ec..t.:roscopy.. For purposes of examination utiliz-
ing U.V. spectroscopy, a Bausch and Lomb Spectronic 600 Double 
Beam Spectrophotorneterb linked with a Linear/Log Varicord 4-3 
Recorderc v1as employed. All solutions for investigation t-iere 
---------·--·--------
a - Corning Scientific Instruments, Medfield, Mass. 
b - Bausch and Lomb Analytical Instruments, Rochester, N. Y. 
c - Photovolt; Co:rp., New York, N. Y. 
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placed in Coleman 30-300 Silica Curvettesa .for the' scanning 
pr·O<!edures. .A dueterium lamp furnished the energizing beam 
for the solution$. in question in wavelengths-ranging from 
220 to 320 nanometers. It was postulated that any alteration 
of the speetrogram.s for ingredients in the ao.mixture as com.; 
pared to their standard spectrogram in distilled \'Jater, would 
indicate a chemical interaction. 
The determination of suitable concentrations was 
required for the production of consistent u.v. spectrograms 
for each individual component. Individual additives were 
diluted from their full strength status with double distilled 
water. These samples \'!ere then scanned in comparison to a 
r.~ference of double distilled wate.r. Once the U., V .. spectra 
consistently measured an absorbance ranging .from 0 .. 2 to 1 .. 0, 
Beer's law plots "~:le.re established for each component. 
Following the preliminary inquiry, triplicate 25 ml 
sample solutions containing .multiple additives were analyzed. 
Using thE! Beer's la1:1 plots as a guideline, proper dilutions 
were made, and U.V. spectrograms obtained for the desired 
ingredient.. IJ.'he reference solution contained exactly the same· 
components, at an identical concentration, excluo:ing that addi-
tive being sGanned in the sample solution, Each sample was 
subjected to examination at intervals of 1 7 '+, 8, and 2L~ hours 
after ao...mixture. In o~cder to facilitate the investigation, 
a - Coleman Instrurnents, Div .. , J?erkin-Elmer Corp., fvlayvwocl, 
T, 1 
••.• !. .L.. 
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only those combinations of electrolytes representing "usua,l 11 
therapeutic and highest physically compatible mixtures were 
examinede Although some additive concentrations were found 
too dilute, when possible, remaining ingredients \'lere examined 
non·etheless for possible interaction. 
Thin Layer Chromatography. As an adjunct to u.v. 
spectroscopy, TLC was employed to elucidate, further, possible 
changes which may have taken place in the solutions. 
Initially, a standard chromatogram for the amino acids/ 
dextrose solution \vas prepared. This \vas accomplished utiliz-
ing a method of Frye (87) developed for the determination of 
amino acid content in soybean products. Glass-supported, pre-
c·oatecl cellulose TLC plates, 20X20 em, without fluorescent 
. . a ~ndl.cator ) were employed.. rrbey had a layer thickness of 
0.10 mm& DrR~mond Microcapsb of 2 microliter capacity were 
utilized throughout this investigation. After preliminary 
trials, 0.5 microliter proved sufficient-to provide consistent 
chromatograms. The spotted solution '11-Jas never allmrred to 
diffuse more than 2 to 3 mm in diameter at the origin. This 
was accomplished by applying small portions with intermittant 
drying. A Desaga template0 proved beneficial in placing the 
origin 1 em from the right edge and bottom of each plate~ 
Prior to each determination, the pre-coated plates ~trere 
a- E. 11. IJaboratories, Inc., Elmsford, N.Y. 
b - Dr-u.rnmond Scientific Co., U. s. A • 
. c - Desaga, Heidelberg, West Germany. 
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developed in Sol vent System I, \'lhich was allowed ~o traverse 
the entire surface before drying the plate.for 5 minutes at 
100°C. Duplicate sample solutions were prepared .for each 
determination. 
Ground glass Desaga-Briru~manna developing tanks were 
·utilized. Filter Paperb, 20.5 em in diameter, lined both 
sides of each tank to insure saturation. Dual solvent systems 
(Table 3) allowed the production of two-dimensional chromate-
--grams-.- Just prior to each determination, the old solvents 
were replaced with freshly prepared solvents. The filter 
paper 'ltlas changed simultaneously. 
Prior to placing the plate in the first solvent, the 
cellulose surface was etched across the entire coating 16 em 
.. 
above the origin. Similarly, a second line was scored in 
perpendicular.' fa;shion 17 em to the left of the origin to 
insure a pre-designated. termination of the migrating second 
solvent front. All plates 'ltlere developed while standing on 
edge. Approximately 8 hours were required for the first 
solvent to traverse the 16 em. The plates were removed, 
dried at 100°C. for at least 5 minutes, rotated 90 degrees and 
placed in the tallies containing the second solvento Development 
time ranged from L~ to 6 hours.. The plates were again dried. 
The drying proc;edures were necessary to insure removal of 
traces of hydrochloric acid and ammonia .. 
Visualization \vas accomplished through the· use of 
a - Desaga, Heidelberg, West Germany. 
b- Braun-Knecht-Heimann Co .. , San Francisco, Ca. 
ninhydrin in a cadmium acetate solvent (Table 3). The 
ninhydrin was admixed just prior to use of the spray 
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reagent .following the second drying cycle. The visualiza-
tion solution was sprayed on the plates until they became 
translucent. Care v.ras exercised to prevent the reagent .from 
running. The damp plates were drie~ approximately 15 minutes 
at 80°0.. Quite o.ften, more time was required at room tempera-
ture .for distinct resolution .. The resultant.chromatograms 
were traced on onionskin paper • 
. 
·Having obtained consistent chromatograms .for the 
amino acids/dextrose solution, duplicate samples of the 
hyperalimentation solution containing electrolytes ana. vita-
mins were examined 1 and 12 hours post admixture. Significant 
changes i:q. spatial arrangement of the components on the chromato-
grams, as compared to the standard, 'i:JOuld indicate possible 
chemical interaction betv.reen the amino acids and additives. 
Micr_opiolog~cal. Assay.. In order to verify possible 
loss o:f antibiotic activity when admixed to the amino acids/ 
dextrose solution, selected antibiotics \vere added alone and 
in combination with "usual" therapeutic concentrations of 
electrolytes e It is the contention of the U .. S.P. (88), that 
antibiotic efficacy is directly related to its demonstratable 
abi1ity to j_nhibit microbial grOi\rth under proper conditions. 
Loss of intrinsic antibiotic activity will manifest itself 
through subtle changes inits capability to inhibit microbial 
growth. This is exemplified by reduced zones of inhibition .. 
The procedures set forth by u.s.P. XVII were modified 
Table 3 
Solvent System, First Dimension 
2-Propanol • • • • • • • 
'Butanone •••••••• 
lN Hydrochloric Acid • • 
• • • • 
• • • • 
• • • • 
• • • • • • • • • 
• • • • • • • • • 
• •• • • • • • • • 
Solvent System, Second Dimension 
2-Methyl-2-Butanol • • • • • • • • • • • • • • • • 
Butanone • • • • • • • • • • • • • • • • • • • • • 
P:r-opanone • • . .. • • • • • • • • • • • • • • • • • 
Methanol • • • ~ • • • • • • • • • • • • • • • • • 
Distilled \Vater • • • • • • • • • • • • • •••• 
Aqueous .Ammonia • • • • • • • • • • • • • • • • • 
Cadmium Acetate-Ninhydrin Spray Reagent 
Cadmium Acetate • • • • • • • • • • • • • • o • • 
Distilled Water o • • • • $ • • • • • • .. • •• 
Glacial Acetic Acid · • • • • • • • • .. • • • • • • 
hopanone , q .. s. • • • • • • o • • • • • • . • • • • 















0.2 96 w/v 
24 
slightly, incorporation suggestioi:l.s of Grove and Randall (89). 
The recommended agar cups were replaced with sterile, absorbant, 
paper discs one-half inch (12.7 mrn) in diameter.a 
Staphlococcus aureus, A.T·.;c.c., 25293, was chosen to 
illustrate the antibiotic activity of Polycillin N, Kantrex, 
Keflin, and Garamycin, when admixe~ individually with the 
hyperalimentation solution. The culture vJaS maintained on. 
nutrient agar slants consisting of Bacto Antibiotic Medium 
- - --
#lb. Bacterial transfers were performed weekly. Fresh 
innoculated slants were incubated 24 hburs at 37°0. to stimu-
late growth and then re.frigcrated. Nutrient broth was prepared 
using Bacto Antibiotic Medium #2b. Both the agar and broth were 
aut.oclaved before use and kept sterile for the remaining assay 
procea.ures. 
A day prim:· to the assay, all required materials v-mre 
wrapped and autoclaved to insure sterility. Simultaneously, 
a loop.ful o.f the bacteria was transferred from the agar slant 
and dispersed in 2:.5 ml of sterile nutrient broth and incubated 
24 hours at 37°0. Agar plates were prepared pipetting 25 ml 
of freshly autoclaved Bacto Antibiotic Medium ill into sterile 
disposable Lab-Tekc 100 x 15 mm plastic petri dishes. 
At; the time of assay, the nutrient agar plates \vere 
a- Schleicher and Schuell, Inc., Keene, N.H .. 
b - Di.fco Laboratories, Detroit, Mich. 
c - J~ab-Tek Products, Div.·, Miles Laboratories, Inc., Westmont, 
Ill .. 
25 
seeded with 0.1 ml of innoculated broth. The innocuJ.um was 
spreac1. evenly about the surface of the agar with a L-shaped 
glass rod and allowed to dry. The various solutions and 
dilutions were then prepared utilizing Sterile Water for 
Injection, u.s.P.a. Five absorbent discs were then positioned 
equidistant about the dried agar surfaces of the petri dishes. 
The sample solutions were spotted on the dry discs utilizing 
50 lambda pipettesb. Following this procedure, the plates 
---- -- - - -
were incubated 12 hours at 37°C. Longer incubation tended 
to obscure the zones.. The zones of inhibitibn were measured 
with a Fisher-Lilly Antibiotic Zone Readerc~ 
A preliminary study indicated 50 lambdas of Polycillin 
N:_0.02 mg/ml, Kantrex 0 .. 4- mg/ml, K;eflin 0.05 mg/ml, and 100 
lambdas of Garamycin 0.08 mg/ml would yield optimum zones of 
inhib:i.tion for the investigation .. 
Each of the four antibiotics was added to a 25 ml 
portion of the total parenteral nutrition solution to produce 
a concentration of Polycillin N, lGm/L; Kantrex, 500 mg/L; 
Kefl.:i.n, 2 Gm/L; anc.1 Garamycin 80 mg/L. With the exception 
of Garamycin whic.h was used undiluted., the antibiotic/ 
hyperali.mentation mixture \vas diluted to the optimum concen-
trations indicated above at one and 12 hours after admixture. 
One hundred J.ambdas of the Garamycin solution and 50 lampdas 
/ 
a- Cutter Laboratories, Inc., Berkeley, Ca. 
b - diSPo Capillary Pipets, T~M .. S/P, Div. AHSC .. 
c- Fisher Scientific Co. 1 Pittsburg, Pa. 
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of each of the other solu·tions \'lere applied to the sterile 
absorbent discs immediately after dilution. Fifteen repli-
cate determinations were made for each mixture. 
The same antibiotics, at the same concentration, were 
added to the hyperalimentation solution to which 20 Meq/L 
potassium phosphate and 10 mEq/L calcium gluconate had been 
added. The results of the physical compatibility study indi-
cated antibiotic admixture in combination with these supple-
mental electrolyte concentrations demonstrated the greatest 
degree of stability. These solutions were handled as outlined 
above. 
Antibiotics in sterile water and the hyperalimentation 
solution without antibiotics served. as controls.. Following 
incubation, the zones of inhibition v1ere ·compared with the 
controls for differences in microbial inhibition .. 
---- ----- ..... - -~--- -----------------
Chapter 3 · ··· 
EXPERIMENTAL RESULTS 
Ph;y:sical Compatibility Analysis 
Duplicate samples of.the amino acids/dextrose solution 
were examined after various admixtures. The nature and con-
centration of these combinations are indicated on Tables L!. to 
17. These mixtures were examined at the end of 1, 4, s; and 
24 hours against black and white backgrounds for evidence of 
physical change. The pH readings were taken 1 and 24 hours 
after admixture. The absence of precipitation, color change, 
significant pH aJteration, or evolution of ge.s suggested 
physical compatibilit~r. The appearance of one or more of the 
above indices, indicated incor.1patibility. 
Part 1.. During the compatibility investigation of 
the hyperalimentation solution and electrol;yte eombinations, 
potassium phosphate was added ,before calcium gluconate. The 
resultant concentrations found to be physically compatible 
are indicated on Table 4o Those combinations of electrolytes 
demonfJtrating immediate incompatibility usually appeared as 
\<~hi te, milky solutions with fine particulate matter gradually 
settling to the bottom of the flasks. Those incompatible 
combinations bordering the compatible concentrations required. 
12 to 24 hours for precipitation to 6ccur. In these cases, 
the precipitate appearE:d as translucent or white flakes, most 
27 
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o.ften .floating upon the sur.face o-f the solution. 
In similar .fashion, magnesium sul.fate was examined 
in the presence o.f potassium phosphate and calcium gluconat;e 
contained in the basic stock solution (Tables 6 and 7). 'l'he 
concentrations studied failed to demonstrate incompatibility. 
It was also found that 160 mEq/L o~ magnesium sulfate could 
be added to the hyperalimentation solution containing 40 mEq/L 
o.f either potassium phosphate or calcium gluconate \vithout 
-· 
evidence of physical change. However, since 8% Amino Acids 
Solution already contains 6 mEq/L of magnesium chloride hexa-
hydrate, furthel~ investigation including magnesium sulfate 
addition was not undertaken. 
The tabulated. pH readings in this part of the experi-
mentation represent a mean of duplicate determinations. A 
standard deviation is indicated in those instances where a 







Physical Coinpatibility.of Potassium Phosphate 
: and Calcium Gluconate .Admixed to Equal Parts 
of 8% Amino Acids Solution and Dextrose in Water 50% 
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3 6 9 12 10 15 20 25 30 35 ~0 
Potassium Phosphate (mEq/L) 
60 80 100 
* - Precipitated immediately upon acldition of calcium 
gluconate. No pH reading was taken .. 
Amino acids/dextrose solution pH 6.15 
Table 6 
Physical Compatibility of Potassium Phosphate 
and Magnesium Sulfate Admixed to Equal Parts 
896 Amino Acids Solution and Dextrose in Water 50% 
·Magnesium 4 c c G 
Sulfate 
(mEq/L) 3 c c c c 
2 c c c c 
··-
1 l c c c c 
10 20 30 40 
Potassium Phosphate (mEq/L) 
The pH of Potassium Phosphate and Magnesium 
Sulfate Admixed to Equal Part's 896 Amino Acids 
Solution and Dextrose in Water 50% 
--
Magnesium 4 6.35 6.45 6.55 6.60 
Sulfate 
(mEq/L) 3 6.35 6.45 6.55 6.60 
2 6.32 6.42 6.50 6.60 
1 6.30 6.40 6.50 6.60 
10 20 30 40 
Potassium Phosphate (mEq/L) 
C = Compatible 
Control Amino Acids/Dextrose 
Solution pH 6 .. 15 
----------
Table 7 
Physical Compatibility of Calcium Gluconate 
and Magnesium Sulfate Admixed to Equal Parts 
8% Amino Acids Solution and Dextrose in \'later 50% 
---- - - --
·Magnexium l.J. c c c c 
Sulfate 
(mEq/L) 3 c c c c 
2 c c c c 
1 I c c c c 
10 20 30 1+0 
Calcium Gluconate (mEq/L) 
The pH of.Calcium Gluconate and Magnesium 
Sulfate Admixed to Equal Parts 8% Amino 
Acids Solution and Dextrose in 'dater 50% 
Magnesium Lk 6.15 6.15 6.17 6.20 
Sulfate 
(mEq/L) 3 6.15 6.17 6.17 6.20 
2 6.10 6 .. 17 6 .. 17 6.20 
1 6 .. 15 6.15 6e20 6.20 
10 20 30 l.J.O 
Calcium Gluconate (mEq/L) 
G = Compatible 
Control Amino Acids/Dextrose 
Solution pH 6.15 
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Part 2. The physical compatibility characteristics 
of the electrolyte/amino acids solution were considered to 
represent both "usual" therapeutic and highest compatible con-
centrations. The succeeding investigation utilized these 
categories of admixtures in addition to vitamins commonly 
employed in total parenteral nutrition. In the absence of 
other additives, all vitamin solutions ·tested appeared to.be 
physically compatible vvith the basic amino acids/dextrose 
solution .. The multiple component solutions were again observed 
in identical fashion as those in Part 1. The :pH readings were 
recorded similarly. They remained essentially unchanged 
(Tables 8 to 10). 
An examination involving a combination of vitamins 
\'JaS und~?rtaken once the compatibility of' single vitamin aamix-
tures to the electrolyte/amino acids solution was empirically 
demonstrated (Table 11). Identical procedural techniques were 
employed as previously described. These admixtures again 




Physical Compatibility and Corresponding 
pH of Solu B Forte with Various Concentrations 
of Electrolytes Admixed to Equal Parts 8% . 
Amino Acids Solution and Dextrose in Water 50% 
B Forte 10 ml/L c c c 
Solu B Forte .5 ml/L I : c c c 
Solu B Forte 10 m1/L 5-73 6.05 5.95 6.25 
.:t.-0346 
Solu B Forte 5 ml/L 6.00 6.25 6.20 6.40 
Ca 10 Ca 20 Ca 25 Ca 15 
p 10 p 25 p 20 p 40 
*Control 6.40 6.45 6.40 6.55 
Ph;tsical 0ompatibility and Corresponding 
pH of I"lVI with Various Concentrations of 
Electrolytes Admixed to Equal Parts 896 









MVI 10 ml/L 
MVI 5 m1/L 
MVI 10 m1/J.J 
MVI 5 ml/L 
*Control 
c c c c c 
c c c c c 
6.31 6 .. 45 6.40 6.51 6.36 
.:t,.0264 .:t,.0264 .:t,.024 
6.35 6.437 6.43 6o53 6.40 
+.0264 .±_.0282 +.0282 
Ca 10 Ca 20 Ca 25 Ca 15 Ca 40 
p 10 p 25 p 20 p 40 p 15 
6.40 6.45· 6.40 6.55 6.30 
C = Compatible 
Ca = Calcium Gluconate in mEq/L 
P = Potassium Phosphate in mEq/L 
*pH of the Amino Acids/Dextrose Solution with Electrolytes 
-Table 9 
Physical Compatibility and Corresponding· 
pH of Folvite with Various Concentrations 
of. Electrolytes Admixed to Equal Parts 8% 
Amino Acids Solution and Dextrose in Water 50% 
]'olvite 5 mg/L c c c c 






- ----- -- -
- I 
Folvite 5 mg/L 6.33 6.1+0 6.40 6.45 6.35 
±·0346 
Folvite 2.5 mg/L 6.35 6.45 6.40 6.50 
,:t.070 
.. Ca 10 Ca 20 Ca 25 Ca 15 
p 10 p 25 p 20 p 40 
*Control 6.40 6.4·5 6.40 6.55 
Physical Compatibility and Corresponding 
pH of Rubramin :PC vd th Various Concentrations 
of Electrolytes Admixed to Equal Parts 8% 







Rubramin PC 1 mg/L 
Rubramin PC .5 mg/L 
Rubramin PC 1 mg/L 























6 .. 40 
Ca 20 
p 25 
6 .. 45 










Ca = Calcium Gluconate in mEq/L 
P = Potassium Phosphate in mEq/L 
*pH of the Amino Acids/Dextrose Solution with Electrolytes 
Table 10 
Hlysical.Compatibility and Corresponding 
pH.o:f Aquamephyton with Various Concentrations 
of Electrolytes Admixed to Equal Parts 8% 
Amino Acids Solution and DeA.'trose in Water 50% 
Aquamephyton 10 mg/L 




Aquamephyton 10 mg/L 































C :;; Compatible 
Ca = Calcium Gluconate in mEq/L 
P = Potassium Phosphate in mEq/I, 
*pH of Amino Acids/Dextrose Solution·with Electrolytes 
Table 11 
Physical Compatibility and Corresponding pH of 
Solu B J!,orte 10 ml/L, Folvite ·5 mg/L, Rubramin 
PC 1 mg/L, and Aquamephyton 10 mg/L with Various 
Concentrations of ElectrolyteEi Admixed to Equal 
Parts 876 Amino Acids Solution and Dextrose in Water 5076 
Sample No. 1 
§~_P:l.~ NQ._ ? _ L c c 
5.90 
c c c 
c c c 
6.10 6.05 
37 
c ] c 
5.98 Sample No. 1 6~25 
+.0346 
Sample No. 2 5.90 6.10 6~05 6.25 
L_ 
Ca 10 Ca 20 Ca 25 Ca 15 
p 10 p 25 p 20 p 40 
*Control 6.40 6.45 6.'+0 6.55 
Physical Compatibility and Corresponding pH of 
· MVI 10 ml/L, Fo1vite 5 mg/L, Rubramin PC 1 mg/L, 
and Aquamephyton 10 mg/L with Various Concentrations 
of Electrolytes Admixed to Equal Parts 8% Amino 
Acids Solution and Dextrose in Water 5096 
Sample No. 1 
Sample No. 2 









6.33 6.48 6.43 6.55 










Sample No. 2 6.33 6.48 6.43 6e58 6.40 
*Control 

















Ca = Calcium Gluconate in mEq/L 
P = Potassium Phosphate in mEq/L 
*pH of Ami.no Acids/Dextrose Solution with Electrolytes 
Part 3. The apparent absence of physical ' 
incompatibility in Part 2, permitted utilization of these 
mixture.s for examination after admixing Iletin .U-40 insulin 
in increments of 10 units/L. The amino acids/dextrose solu-
tion underwent prior addition of electrolytes and vitamins. · 
Observations and pH readings were performed in accordance. 
with previous procedures. Table 12 reflects utilization of 
Solu B Forte 10 ml/L, Folvite 5 mg/L, Rubramin PC 1 mg/L and 
Aquamephyton 10 mg/L. MVI 10 ml/L, Folvite 5 mg/L, Rubramin 
PC 1 mg/L, and Aquamephyton 10 mg/L were employed'in Table 13. 
These admixtures failed to demonstrate physical 
incompatibility over the time interval of study, except in 
t.wo instances "'here numerous whit~ crystals appeared on the 





Physical Compatibilit'Y of Iletin U-40 Added 
.to Various Concentrations o.f Electrolytes and 
Vitamins Admixed t;o Equal Parts 8% Amino 
Acids Solution and Dextrose in Water 5096 
Insulin 10 u/L 93 6.15 6.10 6.30 5.99 
39 
0244 ±·0479 
Insulin 20 u/L ~8'--':"9-=-=------=6=.'-=Cl~4--=-:-_______ 6"-"".-"'0.~5~------=6'-"-.· 31 6. 01 H-~~-~==:......=c:.__:=-~--l-+.0479 ±•0264 _t.0264 .±,.0264 
;·: 
Insulin. 30 u/L 
Insulin 40 u/L 
Insulin 50 u/L 
*Control 




5-93 6.19 6.11 6.36 5.98 
















6 .. 25 




5 .. 98 
P = Potassium Phosphate in mEq/L 
*pH of Amino Acids/Dextrose/Electrolyte/Vitamin Solutions 
Table 13 
Physical Compatibility of Iletin U-40 Added 
to Various Concentrations of Electrolytes and 
Vitamins Admixed to Equal Parts 8% Amino 
Acids Solut-ion and Dextrose in \Vater 50% 
Insulin 10 u/L 6.24 6.43 6.40 6.55 
.±.· 0264 ±.· 0282 
40 
6.35 
Insulin 20 u/L 6.30 6. 5_5--------______,..6.__ .• _ 3 9'-----~1-~~ 
;t.0264 
Insulin 30 u/L 
Insulin 40 u/L 











.±. .. 0282 
6.33 
.±.·0282 
6.45 6.41 6.58b 























P = Potassium Phosphate in mEq/L 
*pH of Amino Acids/Dextrose/Electrolyte/Vitamin Solutions 
a - Precipitation in both samples at 24 hours 
b - Precipitation in one sample at 24 hours 
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Part 4. The concluding study examined selected 
antibiotic admixture to: a) the amino acids/dextrose solu-
tion~ b) the amino acids solution in combination with "usual" 
therapeutic concentrations of electrolytes, and c) the basic 
stock solution with 11usual" therapeutic levels of electrolytes 
and vitamins judged compatible from previous determinations. 
The investigator felt that, in a clinical situation, these 
mixtures should be in combination no longer than 12 hours. 
This would include time of preparation to the completion of 
infusion. Consequently, the visual observations and recording 
of pH values were made at closer intervals. 
The data found in Table 14 were gathered from the study 
O! section (a).· The information presented in Table 15 inferred 
a progressive laGk of compatibility of antibiotic ad.misture with 
increasing levels of electrolytes. The Polycillin N exhibited 
the greatest degree of instability in section (b) of this por-
tion of the investigation. The results of the examination of 
solutions described in section (c) appear in Tables 16 and 17. 
Elevated levels of electrolytes seem to decrease readily the 
stability of the solutions containing Polycillin N. The utiliza-
tion of MVI appears to render these combinations incompatible 
to a greater extent than Solu B Forte. Those solutions con-
taining MVI and elevated levels o.f electrolytes demonstrated 
lack of compatibility after eight hours. The precipitate 
appeared as translucent crystals, which adhered tenaciously 








Physical Compatibility and Corresponding pHiof 
Antibiotics with a r1ixture of Equal Parts 8% 
Amino Acids Solution and. Dextrose in Water 5;o% 
Concentration 
--~ :· 
pH of Admixture (Time ]:nterval in Hours)* 
o 1 2 4 1 6 8 24 
500 mg/L 6.4-0 6.30 6.30 6.30 6.30 6~30 6.25 
6.35 6.30 6.30 6.30 6.30 6.30 6.25 
1 Gm/L 6.50 6.40 6.40 6.40 6.35 6.35 6.35 
6.L~5 6.35 6.35 6.L~O 6.40 6,.35 6.35 
500 mg/L 6.10 6ol0 6.10 6.10 6.10 6.00 6.10 
6.05 6.05 6.05 6.05 6.05 6.05 6.05 
2 Gm/L 6.20 6.20 6.20 6.20 6.20· 6.20 6.10 
6.20 6.15 6.15 6.25 6.20 6.15 6.10 
80 mg/L 6.15 6.20 6.20 6.20 6.20 6.20 6.20 
6.20 6.20 6.20 6.15 6.20 6.20 6.20 
Control Amino Acids/Dextrose Solution pH 6.15 












Physical Compatibility and pH of Selected 
Antibiotics Admixed to Various Concentx·atioil1s 
of Electrlolytes in a Nixture of Equal Parts r::IS% 
Amino Acids Solution and Dextrose in Water 510% 
!_ 
pH Reading Time In:!; erval (hrs. ) ~isual Ex:amina·tion 
T me Interval (hrs.) 
0 2 4 6 8 12 24 0 2 4 6 8 12 24 
6.55 6.60 6.60 6.60 6.60 6.60 ppt c c c c c c X 
6.55 6.60 6 .. 60 6.60 6.60 6.60 ppt c c c c c c X 
6.35 6.35 6.35 6.35 6.35 6.35 6.30 gl c c c c c c 6~30 6.30 6.35 6 .. 30 6.30 6.30 6 .. 30 c c c c X X 
6.50 6.50 6 .. 50" 6.50 6.50 6.50 6.50 gJ c c c c c c 6.50 6.50 6 .. 50 6.50 6.48 6.50 6.50 c c c c c c 
6.50 6 .. 55 6.50 6.50 6.45 6.45 6.45 cl c c c c c c 
6 .. 50 6.50 6.50 6.50 6.45 6.45 6.45 c c c c c c c 
Electrolyte Content: potassium phosphate 20 mEq/L and calciuj~ gluconate 10 mEq/L 
I 
Control Amino Acids/Dextrose/Electrolyte Solution pH 6.40 
ppt = Precipitate 
C = Compatible 
X = Incompatible 
-I=' 
\J.i 
Table 15 (Cont.' d.) 
. . 
I 
Antibiotic pH Reading Time Interval (hrs.)· '[visual Examination 
4 6 24 
~~ime Interval (hrs.) · 
0 2 8 12 ~ 2 4 6 8 12 24 
Polycillin N 6.60 6.,60 ppt ppt ppt ppt ppt J X X X X X X ~ •I 
1 Gm/L 6.60 6.60 ppt ppt ppt ppt ppt ,. X X X X X X 
Kant rex 6.'+0 6.40 6.40 6.40 6.40 6.l~O 6.35 0 c c c c c c I 
500 mg/L 6.40 6.40 6.40 6.40 6.40 6.40 6.35 G c c c c c c 
I Kef lin 6.50 6.55 6.50 6.50 6.50 6.,50 6.50 0 c c c c c c 
2. Gms/L I 6.50 6.55 6.55 6 .. 50 6.50 6.50 6.50 a c c c c c c 
I Garamycin 6.45 6.55 6.50 6.50 6.50 6.50 6.50 q C C C C C X 
80 mg/L 6.50 6.55 6.55 6.55 6.55 . 6.50 6.50 ci c c c c c x 
Electrolyte Content: potassium phosphate 25 mEq/L and calci+ gluconate 20 mEq/L 
Control Amino Acids/Dextrose/Electrolyte Solution pH 6.45 
ppt = Precipitate 
C = Compatible 
X = Incompatible 
t 
Table 15 (Cont .. ' d.) 
!, 
Antibiotic pH Reading Time Interval (hrs.) jvisual Examination 
0 2 4 6 8 12 24 
~ime Interval (hrs.) · 
s. 2 4 6 8 12 24 
Polycillin N 6.70 6.70 ppt ppt ppt ppt ppt ? X X X X X X 
1 Gm/L 6 .. 70 6.70 ppt ppt ppt ppt ppt ? X X X X X X 
Kant rex 6.50 6.45 6.45 6.50 6.50 6.50 ppt c c c c ? X X 
500 mg/L 6.50 6.50 6 .. 50 6.50 6.50 6.50 ppt c c c c ? X X 
Kef lin 6.62 6.62 6.62 6.62 6.62 6.60 ppt c c c c c c X 
2 Gms/L 6.62 6.62 6.62 6.62 6.62 6.60 ppt c c c c c c X 
Garamycin 6.60 6.60 6.60 6.60 6.60 6.55 ppt c c c c c X X 
80 mg/L 6.62 6o62 6.62 6.62 6.62 . 6.60 ppt c c c c c X X 
Electrolyte Content: potassium phosphate 40 mEq/L and calci+ gluconate 15 mEq/L 
Control A1lino.Acids/Dextrose/Electrolyte Solution pH 6.55 
ppt = Precipitate 
C = Compatible 




Physical Compatibility and pH of Selected Antibiotids Admixed 
to Various Concentrations of Electrolytes and Soltl B Forte 
to ml/L, Folvite 5 mg/L, Rubramin PC 1 mg/L in a Milxture of 
Equal Parts 8% Amino Acids Solution and DeA~rose iniWater 50% 
____ .,. ... ___ 
,•,. 
Antibiotic pH Readin~ Tim~ Interval Observation Time 
hrs.; Interval (hrs.) 
1 4 8 24 1 4 8 24 
Polycillin N 6.25 6.20 6 .. 20 6.15 c c c c 
1 Gm/L 6.30 6.20 6.20 6.20 c c c c 
Kant rex 6.05 5-95 6.05 6.00 
I 
c c c a 
500 mg/L 6.00 5.,95 6.00 5-95 c c c c 
Keflin 6.15 6.15 6 .. 15 6.10 
I 
c c c c 
2 Gms/L 6.12 6.12 6 .. 12 6.10 c c c c 
Garamycin 6.12 6.12 6.10 6.10 ·1 C C C C 
80 mg/L 6.12 6.15 6.12 6.10 C C C C 
Electrolyte Content: potassium phosphate- 20 mEq/L and ce.lc~iJm gluconate 10 mEq/L 
Control Amino AcidslDextrose/Electrolyte/Vitamin Solution pH 16.40 
~ 
Table 16 (Cont'd.) 
A..'!'J.tibiotic pH ReadinZ Time Interval Observation Time 
hrs.) Interval (hrs.) 
1 4 8 24 , 4 8 24 ...... 
Polycillin N ppt ppt ppt ppt X X X X 
1 Gm/L ppt ppt ppt ppt X X X X 
Kant rex 6.05 6.00 6.05 6.00 c c c c 
500 mg/I~ 6.10 6.05 6.,10 6.00 c c c c 
Kef lin 6.20 6.20 6.15 6.15 c c c c 
2 Gms/L 6.20 6 .. 20 6.20 6.15 c c c c 
Garamycin 6.15 6.15 6.15 6.10 c c c c 
80 mg/L 6.15 6.20 6.,20 6.10 c c c c 
Electrolyte Content: potassium phosphate 25 mEq/L and calciJm gluconate 20 mEq/L 
Control Amino Acids/Dextrose/ElectrolJ~e/Vitamin Solution pHI6.45 
.:!J 
Table 16 (Cont'd.) 
Antibiotic pH Readin~ Time Interval · Observation Time 
hrs.) Interval (hrs.) 
1 4 8 24 1 4 8 24 
Polycillin N ppt ppt ppt ppt X X X X 
1 Gm/L ppt ppt ppt ppt X X X X 
Kant rex 6 .. 20 6.20 6 .. 20 6.20 c c ? ? 
500 mg/L 6.25 6 .. 20 6.25 6.20 c c ·? ? 
Kef lin 6.35 6.35 6 .. 30 6.30 c c c c 
2 Gms/L 6 .. 35 6.35 6 .. 32 6.30 c c c c 
Garamycin 6.30 6.30 6 .. 30 6.25 c c c c 
80 mg/L 6.35 6.40 6 .. 35 6.30 c c c .X 
Electrolyte Content: potassium phosphate 40 mEq/L and calcij~ gluconate 15 mEq/L 
Control Amino Acids/Dextrose/Electrolyte/Vitamin Solution pHI6.55 
ppt = Precipitate 
C = Compatible 




Physical Compatibility and pH o:r Selected Antibiotic 1s Admixed 
to Various Concentrations o:r Electrolytes and MVI Cohcentrate 
5 ml/L, Folvite 5 mg/L, Rubramin PC 1 mg/L with a Mli.xture of' 
Equal Parts 8% Amino Acids Solution and Dextrose in ~~later 50% 
-~ _.:__-:-..,;--_. 
Antibiotic pH Reading Time Interval 
(hrs.) 
1 4 8 24 
Observation Time 
Interval (hrs.) 





































































Electrolyte Content: potassium phosphate 20 niEq/L and calciuJn gluconate 10 mEq/L 












Table 17 (Cont:'d.) 
pH Reading Time Interval 
(hrs.) 
1 4 8 24 
6.50 6.45 6.40 6.45 
6. 50 6 .. 45 6.·4-0 6.45 
6.40 6.40 6.40 6.30 
6.40 6.40 6.35 6.35 
6.45 6.LJ.o 6.40 6.40 
6.L~5 6.42 6.40 6.40 
6.45 6.40 6.40 6.40 
6.45 6.40 6.40 6.40 
Observation Time 
Interval (hrs.) 

































Electrolyte Content: potassium phosphate 25 mEq/L and calciuJrn gluconat~ 20 mEq/L 












Table 17 (Cont '.d.) 
pH Readin~ Time Interval 
hrs.) . 
1 4 8 24 
6.60 6.55 ]?pi; ppt 
6.60 6.55 ppt ppt 
6.50 6.45 6.50 6.40 
6.50 6.50 6.50 6.40 
6.55 6.50 6.50 6.50 
6.55 6.50 6.50 6.50 
6.55 6o50 6.50 6.50 
6.55 6.50 6.50 E?-50 
Observation Time 
Interval (hrs.) 


























. . I I Electrolyte Content: potassium phosphate 40 mEq Land calcimn gluconate 
Control Amino Acids/Dextrose/Electrolyte/Vitamin Solution pH J3. 55 
15 mEq/L 
ppt = Precipitate 
C = Compatible 
X = Incompatible 
.\J1 
I-' 
~-~~----~~-~---------- --- --- - - ·- -· 
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Chemical Com:patibility Analysis 
p.V. Spectrosco:p;y.. The previously described techniques 
were employed to obtain standard U. V. spectrograms for the.~ 
solution of amino acids and additives investigated. Triplicate 
·samples were diluted with double distilled water at the time of 
scanning., 
A 5% dilution of the amino acids/dextrose solution 
-n--~~~--n.pr-oduc~e-a-a-sp-e-ctrogram-w:i:th-a-A oi' 279-nm-\vi-t-h-second:a~L-Y"-----~~~~-
max 
~max of.267.5 and 287.5 nm (Fig. 1). A Beer's la\•1 plot con-
firmed the dilution best suited for the succeeding analysis 
(Graph 1). 
The examination of Solu B Forte, 10 ml/IJ, produced a 
spectrogram. e.x:hibiting a A of 262 nm when the mixture was max 
diluted to 176 (:B'ig. 2). Similarly, MVI 10 ml/L, produced a 
~ of 265 lli~ for a 2% dilution (Fig. 3). max · 
The application of U. V. spectroscopy become limit eel 
after determining the concentrations necessary for obtaining 
standard spectrograms for the remaining vitamin additives. 
Obtaining a u .. v. spectrogram for Folvite necessitated a mini-
mum concentration of 5 ,Ag/ml yielding a Amax of 282 nm (I!'ig. 4-) .. 
Similarly, R.ubramin PC required. no less than 5)1g/ml, exhibit-
ing a }\max of 257 run with secondary peaks at 27'7, 295, 305, 
and 320 nm (Fig. 5).. In like manner, a A . of 21+1 nm with max 
secondary Amax at 262.5 and 270 nm was obtained for 
Aquameph;yton, 10 fig/ml (Fig. 6). ~1hese data inc1icated either 
the eoncentration of the vitamins must in increased for com-
parative dilution, or the undiluted vitamin/amino/acids/dextrose 
solution would have to be scanned. !I'he former situation 
would necessitate admixture concentrations·f'ar in excess 
of'.those utilized clinically. Scam1ing of undiluted solu-
53 
·tions raised questions concerning the interference of t:he 
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FigG 6. U.V. Spectrogram of 




Having determined the standa:I.'d u.v. spectra for most 
additives, various admixtures were examined. 
Electrolytes. Potassium phosphate 25 mEq/L and calcium 
gluconate 20 mEq/L were admixed to the amino acids/dextrose 
·solution. As these agents precipitated at this concentration 
in distilled water, only single additions were placed in the 
reference solution. Duplicate scanning of each sample solution 
alteration of the U.V. spectrogram·for the solution of amino 
acids and dextrose compared to the standard. 
Vitamins. The combination of Solu B Forte, 10 ml/L, 
~d the basic solution of amino a~ids and dextrose produced 
spectrograms indicative of possible chemical interaction. One 
hour after admi:x:ture, scanning of triplicate samples produced 
a u.v. spectrogram for the amino acids/dextrose solution 
exhibiting two additional absorption peaks at 230 and 262.5 nm 
and a hyperchromic shift in absorbance at 282 nm. The secondary 
peaks normally demonstrated at 267.5 and 287.5 nm were unde-
tectable. The U.V. spectra for Solu B Forte also showed a 
hyperchromic shift in absorbance (Fig. 7)., 
Four hours after admixture, the U.V. spectrograms con-
tinued to modulate. The first peak seen at 230 nm exhibited a 
hypochromic shift to 227.5 nm. The second peak disappeared. 
and the major peak of absorption, initially 282 nm, shifted to 
279 nm with a hypochromic shift in absorbance (Fig. 8)~ The 
spectrogram for Solu B Forte appeared unchanged., though a slight 
61 
hypochromic shift in absorbance was noted. 
The u.v. spectra obtained 8 and 24 hours after admixture 
were essentially identical, and exhibited the most profound 
alteration compared to earlier results. The spectrogram for the 
amino acids/dextrose solutions displayed absorbance at 230 nm, 
a second peak at 253 nm, and a significant hyperchromic shift 
in absorbance at 280 nm. Similarly, the spectrogram for Solu B 
Forte featured a slight bathochromic shift to 26?.5 nm. This 
development was accompanied with a tremendous hypochromic shift 
in absorbance (Fig. 9). This observation \vould tend to coincide 
with a noted drop in concentration of those components which 
initially influenced absorbance at 262 nm in the standard U.V. 
spectrogram for Solu B Forte (Fig. 2). 
These data appeared to suggest the occurrence of a 
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Fig. 8. U.V8 Spectrograms of Equal Parts 8% 
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In like manner, triplicate samples of MVI, 10 ml/L:, 
and the amino acids/dextrose solution were scanned at 1,. 4, 
s, and 24 hours after admixture. The amino acids solutions 
spectra revealed immediate alteration vJith absorption peaks 
at 272 and 275 nm (Fig •. 10) one hour after admixture. The · 
shoulder at 287.5 nm appeared to be retained. The spectro-
gram for MVI lacked any apparent change. 
After L~ hours, the mixture disclosed further progres-
sive deviation. A Am of 267.5 nm appeared with a succeeding ax 
peak at· 277.5 nm (Fig. 11) in the amino acids/dextrose solution 
spectrogram. Concurrently, a noticeable hypochromic shift vms 
noted on the MVI spectrogram (Fig. 11)~ 
Eight hours post admixtur~, the resultant spectrograms 
appeared generally unaltered, except a decrease in absorbance 
was again notea. in the MVI spectrogram. No shift in spectra 
was apparent (Fig. 12). 
The final scanning demonstrated significant u.v., spectra 
alteration. The wavelength of absorbance remained essentially 
unchanged, however, a hypochromic shift was displayed on the 
amino acids/dextrose solution spectrogram versus a significant 
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The Beer's law plots for Jlol:vite, Rubramin PC, and· 
Aquamephyton confirmed therapeutic admixtures were not of 
sufficient concentration for scanning. However, in order·to 
determine the stability of- amino acids/dextrose s·olution, 
each of the supplemental additives were admixed singly, but· 
only the amino acid content was scanned. Corresponding 
intervals of examination employed in preceding studies were 
utilized. Resultant spectrograms for each admixture failed 
to demonstrate alteration, suggesting an absence of chemical 
interaction. 
?1 
Antibiotics. The determination of standard u.v. 
spectrograms for the selected antibiotics indicated thera-
peutic regimens contained· in the amino acids/dextrose solution 
would require scanning of undiluted solution·with the exception 
of Keflin. 
After repeated determinations, the spectrogram yielded 
by Polycillin N, 0.8 mg/ml, was difficult to evaluate. There 
appeared to have been a \nax of 252.5 nm. It is conceivable 
this deflection could have been influenced by analytical noise 
(Fig. 14). Scanning of Keflin produced a A of 236 nm with max 
shoulders at 262.5 and 283 nm at a dilution of 0.02 mg/ml 
(Fig. 15). Production of a spectrogram for Garamycin required 
a.concentration of 0.160 mg/ml yi~lding a ~ax of 256 nm and 
shoulo.ers at 240 and 280 nm (Fig. 16). Similarly, a Am ax of 
256 nm appeared on the spectrogram for Kantrex, 4 mg/ml, \'lith 
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Fig. 16G u.v. Spectrogram 
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Fig. 17. U.V. Spectrogram 










Having previously established a Beer's la\'.r curve for 
each antibiotic, single admixtures of each antibiotic to the 
amino acids/dextrose solution were prepared. Prior investi-
gation indicated, with the exception of Keflin, that thera-
peutic concentrations were of insufficient strength to produce 
u.v. spectrograms. Consequently, only the amino acid content 
was scanned 1, 4, 8, and 12 hours after admixture. 
The U .. V. spectra of' the solution of' amino acids and 
dextrose containing Polycillin N, 1 Gm/L, appeared unchanged, 
except f'or an absorption peak at 224 nm. This secondary peak 
remained consistent throughout the 12 hour period of' examina-
tion (Fig. 18) .. 
Upon examining Keflin, 2 Gms/L, mixed \IJith the solu·tion 
of' amino acids and dextrose, a hypochromic change in absorbance 
t,ras noted (Figs. 19 ana. 20). The· significance of' such an 
alteration in absorbance remained unclear. 
The U. V. spectroscopic examination of' Garamycin, 80 mg/IJ, 
in the solution of' amino acids and dextrose suggested an absenee 
of interaction (Fig. 21). 
The final examination of' Kantrex, 500 mg/L, admixed to 
the amino acids/dexGrose solution, appeared unreactive (Fig. 22). 
To further evaluate the results of' the U.V. spectro-
scopic investigation of' the above admixtures, a microbiological 
assay (pg. 86) \vas performed to provide a more definitive anmver 
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U. V. Spectrograms of Equal. Parts 8% Amino Acids S.ol'!ltion and Dextrose 










-~~--~~-~~-~--,~~L2~9~-~ • I : 1 ; ! ' l ' ~ • • I .j ! 
, ~ •:. 1,.,, 1 trt,Jtii r~·j, 'Til 
--'-..;....;.+---4-4. -~~7! :+++-: H.~: ; ·;; 
-'-+--·t-{ '!:hi! t::idl\! \!\~:!1! 
j·: 1 ~ -;--T:.i ~~.~-~;r.T; ~-~·~;-ITT! 
I. I. ! '1''' !:·:·I! ;·,ij· I' 
1--·1-----.,----. • : . + _ _[_, ___ ~ ._; :_ : :..:.+~- ·_:.;_~ .:..:JJ_ \<l •. l' !'·!;::· ,:!'!'!,: ::: ::: i ~--:-~ ·-------1----t-·--- .......:..---r--... J.-1 o~ ---• ... j \: .. !::: . i. , .... ::~ : .. !i!::!;~:~~:~!: 
- \--t--: I~----~-.. -- ·r·· :- - ·- :··r;:: · :~ ·1 ,...~-· 
:idl i i .~ ... + .. ' 
·:-:--r-r.~- _____ [ ... ~ ... : i--~1.....:.:__ .__:.i. ::1:!:~~ d~_:'.! ::;. ill 
~! ·:: PL:. -~:~ 
::::;,>: -~~-~~·:-l~,i'~· 1, 
.. -l' ' ... . . . . , I- - I . ' ... I . I . .. . . . .. ' ' 
' . . : . . I . ' . . . I : I I ' . ; . : ~ • • 
. : i . ~ . . I . I . . ' . : . : ~ ~ : ; ! : ! . : l ; 
·c· . !\ i/:--r.:.: l. ~\ :; \ :L:. -:'~: ,-:r-n 
-- -·· --- ---. l ---·- ---- ... , .. --~..;.~ . ... --~ ' ....... ..:. 
. •I . . I .. ' .... , .... ' ' 'I: 1 
.. ·I\ . 'i ' . I' \ ... : . .. . ' I' 
: ~- ,f; :: ·: .. : . :;!· :·l~: 
· · · i · \ · /:I · · · .. 'j \: :':: 1•.;: ! I l F~·:·!-:;·~ /~~t~~~ ~-u: t;'t ~;tTf:. -Ht 
·i< !::: \l}::: 
. I· 
bf-- I :t'r'tt-. ... , 
Fig. 19. U.V. Spectrograms or 
in ltlater 509b (left) and Keflin 
Wavelength (nm) 20Q .. 











::J:I!ltlt':_l''l:::li·''·';I.'''H·':I· ~~·~ I I! . ::; ; :-1: ! ~ :I : t:': .· . . . . ' . 
1 \ ! I ! . : i I I I ; 1 l j ~ : : t ' I ! ' ! I t : : : : I ! ! I . ; 
r~ 1 r i 1 !j: 1 i i ~--r :··::·-~- -. -, -~- ·---r·--. · 
: ! j i l I I : I j l ; ! ; I : . : ' ! : ~ ! . I ! 
~:·~: , : :~ -;~1 .. ,.-i. r ·;~~-i--:-~ -~G--· ----r·:--· 
1 
::.E ~J;,'· :~r· ~- L~- __ L ________ L_ 
-sf+ ill: 1 i -, H , 1- · : -
• "I , 11 · r tEE· 
D
V<.rt: ·w,N _, I I P1 ~ .:.L .: ' J(i 1: : ) : f, : ; : i . . !: : : ; . : : : •. ,. ·~~-- ..L:~-·· --~- -r------··· ·-r----,..- --~ i ·,~\ ll : : 'i \ ~ ll ; ; \ · : ~ I ~ ~ · ; . ! .: ~ . · · , . ! 
... .tl.-+-·· ., __ H ..... 1 ... , .. -' ..... ·t··---+·~ ...... , ....... .•.• 'I" . 'I . I . ..  '  1. pi: I . 1 ; , i '; r' · · .. . . ' .. ; i .. :~-.II . I . . \' . I . . . . I '·~ ',, :, . ·t" I' . ·: (~' ,._:~ ' 'I i-; • -··- · --- ---r-:-7 • -r • , :. :I· r · : t:, • • \. r::l . . . . ·... · . , · ··: 
' ' . \ i ' ' ' i I l : ' 1 : ~ ' · ' .... · ; · • ' ' i ' ' ' ' ' ' J ; : ' ; 
----- L~-!--•· -~-1-;l·-- _, ___ J_\·•··· ·-----f' !...!.., .. ·----!-;--~~ 
. :>I: i.: :; ; :I :: . :::: . \; :. . '<: T::: I;';: 
• : • • ' t I • : • I I • • ' ' I I • ~ I ' I ! ' ! I ' ' . 
--;-.3~1,''- ' I.'-, - - I . ! -r--
.. 'I' .... I ., ...... r . , 
i!: l : l: I! 1: i: 1: :::. :I' . . ; ! i: 
··--, '·'-·• . 'Tj'' ' ; -, . ·-•, j . •-- • ' ·- ·I •·• ·r • 
I ; ; : i ~ i : i l • I l • • ; •; : • : : 1 'l : • • : ; l ; 
:......z-+-i+- · · · · · '- · · · · I · ·. I -· · · ~u 1 i! i Wil" l· ! hl;: , , ? "" 
,,,, [,!, ·d·" .. ,., .. [ .. ' 
j ~ b: i i: : rtit ~:t; ftt~L. ~: ~~tn: ~ ~-~- ~. 
Equal Parts 8% .At"llino Acids Soljbtion and Dextrose 














vlavelength (ni!_l) 2 , 1 o:: 'ti.' :7."",,.· 
8sr-~+:-:-! t_ : l i ! ~; ~ l i : ! ~ t : : : i : : : : i 11 · i! i 1111 t ! I ! ! I ~ ' : 1 ~ I • I • 
. . • I I ' ' I ' I : ' ' : I -~ :· : ,,. 
" I : " . ' I . : I ! i ' II I ! : : I I I I ' :· I ul ~-r- f-ii;;· ·~~·~,:!:: :j~' ·t: 
L._L..:__ .-~-L..:.-1 -·.~ -- ~u- --t-.1 ~ ' I . I .. .. ,. .. . . . . .. . ' '' . . . i : . . . ..
I\ ! . I •. . I ·. ; ·I ·. ·. ' I ' I I' :. . . l. , i :: . : i ; ': t-T--.1.__ -'-·-- -···-~.- -1.0-t--r-· 
'11 J:: ,. ; j . ::· : 1: :::,,!:: rr-·v·-. ----: --- ·j··' .... ··--. ·-···j ~.-~ .±~l:~.~i+ t~rrm HH ~I\, I 
or .. ,, I''" .;.,t~ ·i·~-+,4-!-i!l. . l : ; ~ r 1 ; ; 1' 1 i ; i i : ! ; ; : ~ ·1 ·:::-J::r ::l! : ,-:-: :r: h-:-: l: ::: l: . ·:::i ::-,: ~t~~~ : 7tp 
l · .. ··r·· .... "·' .... Hfl.;.,, .. , .... ;!~ •.. . 'I . . . " . . . " . I I . , :. . . . .. I.:. '; ... : . . . 
! ; : : J ~ . .: : > .-: t i . : ' . -;6 . i ' i ;: 
I ........ -"I . '·I,... l .... ,.. . . . .. I +; I :: ;j : :: l : : : ' ! -.: . . . HI I : i !---t·--·--· ·-' +--'-- -~- . .. 
, .• ·. ! •. ·--c·~.,. ;:l I \ .. ,/ .. \_... ',., ~ : .. · . · ~-· :, . .: r -: : . : : · 1 , ........ , .. ~~ . ru 
I : : : i : •· : ; tT·, : : ;:·· ~ ,, : i ; ~ : : ! : i 
-..----iL- .... ,Lj..., , ...... __ 1_ .... , .. ··-.·r .. +,·' 
. • . .• . . ·I . . • . f. t' . ' I 'I • .. , .. ' { . . I ; . '. ; ! ' , :. , . . 
; ~ ; i 1: ~-1· .. ; : . : ' -~ : : . ~- J•< : ; l : -~_._L._: ~ . ..:..:....1_ :.~ :. .. .. l~ .. - ..: : : ·, ~.;.... • '..: 1 
... I' l . ' • • " . I . ' :t. l ,. 
• , . • . . : • . ' ' . l . I ' • ' , ~ I 
1. \ , .. -~-~+-L_ -~ : ~ . .Ji~l :; 
I . . '·I'. . '. .. \• I: I I . :. . . . 'I I '; • 'II 
• - ... - i - . . • - ·- • I .. . • . ~ . . . .. ' ... . . l I 
I·:: _L __ lL. _lL. : · :_ ~~-~-· ;.~ ... , 
~-~.. :.j:.:· .:;: ,; .,, l!7j 
+~~ -: :... :·H~ !~-:-: : t! i r -,: i r: · · : ,, l h , 





Fig. 20. U.V. Spectrograms of 






; iii iII I I j illl ; i ::! i iii; iii j i :! : ! ::: 
··-'-~ ··~ ·r:! :ji: ij;:f'li: ;: 'i; r 
-:-- .. ITt~~· ~:-;-:·r:-:1:, ~-- '+J..I +: ~-i ;_f~~ -:, .T:~:-
; I • I I ! I : ! ; : ' ; ' • I . : ,. . ' ; 
I • ·'I • • , • ' '! • '. t ' j' 
II. ' ., I I"' .. 1.· .. ··J·"I 
,,;--;-: :~: ::;·:1-i··· ~-::r-~·i: -~·t:;.:..~ -~:~,::~ 
r I I , ----;-· _:_.,; 1 r~ • -'-' ~IT' : ~-+-, ;_ __ ~~ 
I •1: . ' I • / I . J . : 1 1 • : I ' I I'\:' :'. /l ., J\ . :! . . I I:.:. :: .I 
•·: . • ~. . - ! . . . ' ' • .., ,_; . - .•.• 
I ' • 1 I I l ' ; ' : I ; . ' . . .. ; ·! . : 
. I " : ' : • I ,I ' ' ' : . ; ' 
\
1.. 1 • • • . · I · · · .. · t [ : f I \ ' ' l ' ; : r l 
: ' . ~[ ~ { : i i : ... · : . ', : ~ l : : : . 'j\ ; ·: ! i : : j· . ..: k. I'. 'J • ' \ ' .'.. . • . . . . '.'I 
i:11 iii! ·:l!: :"fTfl~i!~ .4 - :~i: :L:t>:: 
1 i l .. j. I I'll i J ; :. ; : \-:-: it;·; I i 't: !';·: i 
'I • ! ' 'I ' I II '1\ l '!' .•. ' •. ; ' 
! i . ~ ' i : ~- : ' I ' • 1 n· ; i i : . : r, j·r ; j ; ; i . i ; ; ; . ; : : -~ -l .. l·t·•·' .j[,J~L. i .. • , .. _, ... ,L .. ......, ....... ....; •ti· .. i--"·• ~j1' +h :w :; ~~ ~:1 ~~ llk I : : ' ' : : I : ' 
. ll ' ··I . . ' ! ' I : . j : ' .. , ' ... , -- .... t·"· ... ... -- I -- .. 
1 j : j 1 i . : : : : I ; ; j : ; ~ i : . ; ; ~ . i ; :~~ ~ : : ; · 
·...,-~-:· "-·-'·". --+··1--1-·-.. ------~ .• --"--· ----1- -·- ~-r----
1 l ! j i ( . l l: 1 j :1: : ! j j : j j i L !j ~ .;l l; li; : :·;! i 
II.' I'; I . Ill ,. :1' :''I ,J j' '':. ':!; '.I .• ; ; l i ! .;;·' 1·1' \~.~ '!. 1 ll'il ~:t· :t:t t!~t ~-~!! 
Equal Parts 8% Amino Acids ]solution ~nd Dextrose 












i ' ' ! I I 
• j •• 
. : i l 
~ :J..\ 
~ j i". ::.,I 
; : ! ~ 
~--
Fig. 21~ U.V~ Spectrograms 













1 ti 3~0 ' 
!II ._. ; .. --, 
-'-'-''-+·+"--'-'-+--1---l : ' ' l ::: L-J 
! l: ~ f\! t: j: l:, :: ~, ,-.. ..~ 1 -: .-,,:: : 1, ' : i ; I' i 'I: I ' '" : I I .. • • I ; :: i I 1 ! ; ! : ! . ; i . r : : ~ : ! . , ; l ! . ; · ; ~ ~ . 
: ~ 1 '· : 1 i : :I! i ' 1 , ! :: : : , l : : : : : I : · 
IiI· ''I' II!! Itt': 'I i' I ; : ·_ ; :: :: ... ; : " l.L'. II I ! ! I:': I:: '::.I::. . . ! ·I''. ·I· .. :! H1 ~ 1!!; itl: /JL: ::)·::~~: :.j·: .. [:::1 ~- ~-,~~, -; :-r--t--,- :-·-·- -"-,---: 1--:---: t---:-_· +--r. : :: • 1 i": I ; . : ' . · · · .... :. : . i <,.;:,~:IJ::.,·. :~---, : ; .. : :· 
•_:! ! .. ! : • ~: ;_; ' i ' -: c . ;_ . ; -' - -. - ~--· ,'- . :. ; : ~ ;: 'j! • \ l: 1 1 • ·, • ' f : 
' I I .II '! .,. - ' . I . • • I ifi·t i ., :- l::; ·::,. . .. ; -, i . I: , . 
\ i! IJ 1 I I :I. I' . . . I ' .• t -'-'·-~· :. : ::'-.r:·_· __ :_:_ i--- .c_.L: ______ ...::' 
! ; I llil t i i! :t;, .. : -: .1· . . , ·I' . :l 
I I. I, 'LL: \ t • I' I • • • ' ..• ) ~-r::1 :-;I ~-,~-~-1 :-r.··--:-- -:·r--·-:- ~~--~ : ~ ; :- • i .
1 
.. : . ! . • . ~ , ; : . . _ I 
TIIf Trri J'-:H:-_: i ·:-··: i- ~: ·r :·:: F~ .- ~--n 
'!': )t.;i;: :I i:! i ;; l ... : \ : 1: . J' I: . : 
'•'·•hi··•' i't'•·lt•<·· ...... ,.,. ff~·-l·j---·j··-- I-I .• , i'! II . I' )' I.' ' . • . • . I 
I' ,., ; I' ! I' ·I : .. I '. . .. :. . . . . ).~: ~~ i:' I I:; i:.;: ':I::' :! \ ; :) :; .. : .. :; \1·!, , I;;/ r:.' :·::,I . .,., :·:--:·: L-:--. ·--: ~t 
;._4 :·I I! :I i /I ':\: . ,_: < i:: . ':: :L::. . . l 
ji'il i!i: :f~1_-;:,;:_\ ;;:: ;. :,; 
·I I' l' lil:l':i' ;•I' "'~ •. ,. i• .,·; 
·-; r-1~w'--1 -t-111 i 1-h+t:i~' :-;: i1' :·t: \ ; ;~-, -~ ;~~ -:7 -l3 i!t; ~~~,;!!:;~: ~:!:··~~ :;;: ;;•; ':;; 
-~-{-U~-tl1tf H~, ~h·1 ·:+F· \:!~I~- 1.::H .:..d' ,J!: 'i,: ,1·: ~.:J..;i.L' .:..::::;~_=1·.: 
iii! 'ill f~;,· );j:l ,,,j,"!;, ,,·,· ;.~- ;--:-~. 
:I I ! I t!! : ( i. : j· :! ; ' : L'. ! 'i '.:. 
-t -
1
·-l- T -,: j·f·r·ji8" ;·;-~ :· •-;-;I '-:--;--:· -:-~..,. , ~.' --~-:-:-i I \ i \ \ j ~ ! '. ~ ; ' : '1 i I ' • ' I ! ; ' • , 
::-1, :~~: -H1:+ ;} -.:-hf:T:'::
1
;::. :,·
1 l : 1 I ! I I ~ : ! ; I ~ : I ; < : ' . ; : . ; .. : : . ; . . . 
+-t--1--•- .. L. -t -- "1··1 _--'- - --· -- __ , ...... ~----r· . ~ --- -:!li !! i !ii\':.:: :-:··; (~:_\:~ 
I 
of Equal Parts 8% Amino Acids Solution and Dextrose 









~?~ 1 . . I . .~712 . ;_ -~· _, _, ~~ -L' Wavelength (nm) ~P, 1 =l"" _ _it£ __ , , __ J__ .3f0 , ' 
·; :·:·· -·:! !:,T-t-:, :1:: ~~~n~ 1 ,.r:,!l 'i! ~J!l[I!ii:~~~lliLLL~_:_~-~-J :i:G~j·-·J 
I \::::;, :!!; i::: ili;jll!! !Iii !if: liil !iiillii; !~:li 1 ···l·!iiT!:: :1 ri i ,; : :i:rt;+;i: ;:,:,il :1 ' ll.i' :,:; :'f~,!;ii ~~~~~- ;·,.;;~:· 
. ; . I : . . ; . i ' I i i . ; I : i ; I I I'll i i i i I i I' I : I 'I iJ I ; l ! I i : . I i ; i . ; i .. i' : : :- . ! ; ! i I 
·I·. I!,; , :I: II! i I . ; i I!. I I I :1! i! I! ; I I: II::. I:: i • , :·I .. ! : -~ .. :._ .. !~:~? ~~"·, t • ~;r; 1 [;; 1· !i-
1
:1-ji i~iil :ii: ill~;;!!'<;: ___ ;;j;,. · .. ::i 
1 - : .. 1 ' .. - 1 . , ·. • • . 1· , , I : I 1 . 1 11 1 • 1 1• , • 1 I 1 !· I • 1 ; 1 . 1 1• ; : • : • ! . ' 1 ' • · 1 .. • • 1 : : • - - .. I J • : I • ' ' I : : . ' ' . . ! ' . I I I J i . I I . I I . i . ' ' . ~ I : ' I I : . ' I • • . • • '···'-'---'~- ·---· .,.J ..... ·-··.·. 1:1. 'l'ill'J., .. ,,, ''j l,·jl, ,1,, r''l·ri'"· ·l··j·.•: ,.,.,,. . .. 1 i . i ' • i ' ' I . : ; . ~ I . . I ' . : : : ; l I • I I I I I l : I r I ' • 1 r . ' I I I I I I J I I ' I ' . : I I ' . 
i: • -; •• -;' :: .. i ' .• i;, i i '. Ill' 'I I 'I I i 'I . I i iii I'; I IiI I I I I i 'It' i ''.' ' .. : :. -.... 
::::::i;;_ :::;:i:~~·j;;:;l:i:: 1 ~!\:,:li'l.)\!iilli !H' >max u:.'liil! ;].,i\!:i:~ ;~![\_;:q<;:,j::-: :;.:! f1 :~~. -n- ccf> : l;mt: 'J if@T]}T ~~;ulaer 1 mtn: r: . 'lTi'!f[IT! · r~ r:rr- 171 
.. 1,. ····- , :-•1·· 1,, •. ; '· .,,:l•·i'''.''! 1 1 1 2o7 5 111 1 :.• .::··:•:· :··::·;· :.::· 1 :•: I·· : L.p---~-t·:-:-:- r-·:--:~1· ~~-::;-;·:·;: ; :-;--:! ;-'-;-' j :·H tj--~ ·~·i-: -~~~ 287 -5 ,~1+; ·-;~~-:- ·:i i-, r :·i-;; -:--· :~~:- ~ ·t ·-·--.'. ~-+---~, 1- . :I ! _, 1- : : : : : I : ; ; . i ; . ; !; . ! . I ; ; : ; I : i ' ! ! ; , i it' i'~ . ~ - I" : 1'1. i : j : r:-:1: i ; : : j. : ! ~ - . . · .•. ! ; . . I ... ! ' - . . . . . . . I 1 ' . . ' ! ' . ' I • ! I ' l I j • ~' •. ' ! . . . ' . ; . . .. I . -L..:.. . . I f : :; . ' . . . . . I . . . . . - . I • ' . ' . . . I I ' I l • ~ I : ' I • • ' ' •• : •.. · ••• I . . ' .. ::d~·::: _.: :::1·: ·:,:• ::1:! 11:; 1 :1!!.'!J:,!:I :J: l!!t !t.r:!::!: 'ri!!· 1 '1':.'··:~-r: j::·:t 
L : : ; : · : . : . : 1 : ~ : . ! : ~ : : : i : ! : ! 1 : i : i : 1 i 1 1 : : i-i · i ! i :1 i ! : ! : : : 1 : : , i 1 : : : : : :: : 1 t i ·1 > J 
,,I,, , , , , , , 1 , , I 1, • , , , , •, : i , l t l • •: I :! , ·I I l , . • [ l 1 , . 1 
.. ; . . . 'I\.'-. I .. ; . \\I! I! I , II'\:; I\ ! ,I :I I ·II:.:' :::I .. ! ; j·; i' i -; ! •• I\- '' :-:-.- -:~---- - -~L --:·;-: j·--;--- ·~-~-: :- :-; r-+-t;·: : I: .. L!I ~·· ·i •i·i ",·~~ . tr·: jr 1Ti· ~~~~ 1, ... : -,1 ;· • CT"~- ;-;-cchc-r;-' 
. :; :. - : ; :: ! :; :I;:: ::; i;;:: ; i;: :::: ; :-t- ~tt1:-t-':-:-f::; ::I~--.: :; ~; ~:::; ; :: 
. : " ' ; : . . . . ' ' . ; ' . l -. . ' I -\ ; . ' I . i : i I ' I ; I I . i ' I . I I ' I I ' '; . I . I : . ! t ' l ' , ; ' ' ! • . ' . • . . • II ~ . . , . ~··:-~:t::i: ::·:t:?:·~ :.:::,jJ~; ~J1jl~;~j ;)ri iit: ~ 1 ·\: !·t·l··J:i·J-~-f··~·-;·~+1-~:··~·:--f'~:.;.i~f_:_:,_;-. ·~·-:_~~-: ~---f 
·····•·.'· ····I···· ··i· \ill ;,f:l:i'' ''I ·1·'8'' !JI: 11'1 ,J;,J• .•. i I 'til ,, L ::1'" ;. I 
::: :.;~:; ! . ::~- ~:::: :::·''~:: ·:\!El .!-~ :·:: -~:: !~~~~~f~::.:-~-H-:-;--f-1 
··: i'•• P···· ····r~-, ··1:1····. ,,! :' 'II -!1' :,·: ,;!: ••.. , .. ," •. , .. ,: --:~:..1 ~-~~"' :': !;Y~-:U·t: ~.:,ilL,::!!:':· ,~~~r :rr:;~,r;·: -:m:{': ',ll\'~'m. I;--~ 
___ .. ,, .. ,.. .. .. ,~'Lc ..... . ,..,_-... ,.,:Y .... ~-.·--:-·j-•-- -'.i~ij·'+•·· .. ~!.should r __ , . -,- :+-l·:f--"-- -., .. r~1-- 1 ·--- +---.,-.,.~-- ---···--· 
. . . ; : ·.j: r:: : ~ j : 1:;: · ; 1 • ! i!; r · ; i 1 i ! 1 ~ ~ ; :; e • :! : \ 1 . . ·;,: ; t 1 ~ ~ · •· : i i;: = i.: :; : · t 
, i· .. ·!;-' .. '·''I' ... ; 'II'::,' :JI. •; 267 5 I l ,,. '! /' ;' '·:''1 ·1· ... ,,, .. :·'j 
: . ;·t:,: .. :, :::: ; :: · :-r· : i; 
1
:::: ':·I . ; I;++ • :1 ·: ,\;:. , :·v-f-tlli·;:. /1:: .•· . ; :1 i;, ; : · > 
''I'll•' .... 1 li· ;,.1.,! ,r! ,I•, !/1 l•'i ,,1287.5 111·1'\:1 1!'i ;.\ · :ti:I',J ·:;TI, r·:· '"I~ -:-~·~- ~~{+~~-~ 0.·~-:--:·-i-- -~-~-!-.. ,·~+·!~ .. ·~-~-i· -;-+~~- ·~-~ 11~ i- · \-;-: • ~r- -r+r ··7 r~-. ~-11 : ii ... rl:-:· :-:-0-
.. ;.j.. 1 .. , ;" ·::·j· :L ::;; ·•: .\:: •1 ,:· :·1 jjl 11 '" .f, j''!l, •il''1l'\t· ij ·!;. :i" 1 • 't . . I . I • I ' • • : '\. • ' I I ' I I ' . I I • I I l ; t I { . . . . . I ' ' • . I : jl • . • . ' . ; .. : . . .. . (. : . . . : : ; . . ~ ; : . t : ~ : . : : : ; I . : :.3 ; ; . : ·~- ~-=· ; I : ~ : i : ; ; ~ : : ; ·. . : : ; I ~ ' ; ! ~ 
. ' • . . I - I . - . ' . 'l" ; . I . : .. I ; i " ' ·, ! I . i ' I ' I I I II ! II : ;; I ; ! ii.. : I ., I I . ~ ... : ' i ' !I \ ' ' j : ! 
' .. I .. '--. --- . : .. : . . ! : ~ ~ ~ ; : : ' ; I ~ ! ~ : ' l I ' : ' i ! I I : I i 1 . ~ l : I t I : • 1 . : ! : j • . ; . I f l : i i . : I i . --~---1----------·--i---c-- -.---'---·----r-;-n···- H-~~~- --rr ~·lt ,, . -~~~ .. ,.,, .. ~-~~~~··-·· ····r-·-'-- ..... I . I . • . " : : : I : ! : - ' . . . I . ' . , ' ; I ' I ' I ' • . i ' I ' .. I . . '·' " ' • ' , ,. • • ' .:.·,~_, .. ;;. -•~·''f!lil!ij'•:'!! liji;l!lj··l 1 j•l''ji~'''j·· ,-p·l-~~~4~-l- iJ- ~Hl1t -rt~ : i ill iil~!~l, +~iW ~'IT~~ 7h~ m -..... l'. 'il'·l'd'' ·r,,' I ; ! ! ': ;l·j:' ·-:.!•··!. 'II•! ·' - I·- . ; ; . • . . . l .• I . '.. • ' I; I': I, : ' I '' I : !·: •. ' II:. . I~--t-::-· ·+:'--;; .: .. '+'1--::: ·iii· ' ·t r[·ll+-t+ ~ri+·--' :.;..:Ji·;:-;-: ~--:..;-r-:-~ -~--, t-. · ~ · :I: ;. ::- ·:' : i k_iL.!; JJJ ~ 1 \: i \:: A i I; : · ; : r' 1;:;: :,:\I i :-: -. ·: l 
1 hour 
Fig. 22. UoV. Sp~ctrogram~ 
in \'later 50% in combination 
"" "' 1 P ' · Bo! Am. O.L ..... qua ar-cs ;o ~no 
with Kantrex, 500 mg/L. 
12 hours 





Thin Laye~ Chromatography 
Duplicate samples of the amino acids/dextrose solution 
were employed in the development of a standard chromatogram. 
Utilization of 0.5 microliter· required 7.5 hours for develop~ 
ment in Solvent System I, and 3.5 hours in Solvent System II. 
Having established a standard chromatogram (Fig. 23) 
duplicate samples of the hyperalimentation solution were sub-
jected to admixtures of 11usual 11 therapeutic levels of electro-
lytes and vitamins. Similarly, 0.5 microliter was transferred 
from the samples 1 and 12 hours after admixture and spotted on 
separate plates. Follo\IJing development and visualization, the 
resultant chromatograms were compared to the standard. 
The comparative chromatograms on Fig. 24 may be sug-
gestive of chemical interaction at the termination of the 12 
hour period of investigation. One component of the chromato-
gram vanished; another exhibited a loss of spatial continuity. 
Conversely, the spatial arrangement of the chromatographic 
components of Fig. 25, appeared essentially unchanged. This 
latter graphic representation was suggestive of chemical 
compatibility .. 
~--~-~--
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Fig. 23. Standard Chromatogram of 896 Amino Acids 
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Fig., 24. Representative C:b..romatogram o:f 8% Amino Acids. Solution and Dextrose in. 
Water 50% (1: 1) Combined "~:lith Potassium 'Phosphate 20 mEq/L, C!3.lcium Gluconate 10 
mEq/L, Solu B Forte .10 ml/L, Folvite 5 mg/L, Rubramin PC 1 mgJIL, and Aquamephyton 
10 mg/L. · 
--- Standard Solution 
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Fig. 25. Representative Chromatogram of 8% Amino 
\'later 5096 (1 :1) Combined with Potassium Phosphate 
mEq/L, NVI 10 ml/L,_Folvite 5 mg/L, Rubramin PC 1 
--- Standard Solution 
--- Sample Solution 






·I 12 hours 
Acids Solut:ion and Dextrose in. 
20 mEq/L, d(alcium Gluconate 10 










Results of Mi.crobiological Assa;y 
An evaluation was undertaken to ascertain the degree of 
degradation or interaction, if present, of selected antibiotics 
admixed separately v'lith: a) the· amino acids solution and £.) the 
amino acids solution in combination 'u'Ji th therapeutic concentra-
tions of electrolytes. Potassium phosphate, 20 mEq/L, and 
calcium gluconate, 10 mEq/L, constituted the additives in 
section (b). Any significant decrease in potency 'I!Jould mani-
fest itself as a reduction in size of the zone of inhibition as 
compared to the control. 
Polycillin N displayed a dimunition in its zones of 
inhibition relative to its aqueous control in both section (a) 
ru1d (b). Refer to Tables 19 and 20. The activity of Keflin 
appeared to be en_~anced in the presence of either solution 
(Tables 21 and 22)c The efficacy of Kantrex seemed unaltered, 
if not enhanced, in each set of sample solutions (Tables 23 and 
24). Garamycin maintained its activity in combination ~:lith the 
876" amino acids/dextrose solution alone and inconbination \·lith 
electrol~tes (Tables 25 and 26). 
§tatisj:;_ical Evaluation.. The variance of the observed 
data from the microbiological assay indicated a statistical 
analysis ·was requi:eed. to evaluate the significance of the 
altered zones of inhibition. Consequently, a "Student t" test 
was perfol ... med. Tabulation of these calculations are found on 
~['able 2? ~ 
The efficacy of Polycillin N, Keflin, and Kantrex in 
87 
the amino acids/dextrose' solution, -with or without electrolytes, 
did not appear to be significantly different from control 
samples prepared in sterile water -(o.2;,P<O.l, O.Ol>P<O.OOl; 
0.2>P<O.l, O.l)P<0.05; 0.5~P<0.3, 0.5>P<0.3). It appeared 
that Garamycin might be significantly more effective in both 
hyperalimcntation mixtures than in .sterile water (P<O.OOl, 
P<O.OOl). Hov1ever, further investigation should be completed 
to evaluate this statistical significance. 
Table 18 · 
The Inhibition of Gro'."rGh of Stanhlococcus aure~ts by 
Polycillin N at a Concentro..tion of 20 }{g/ml in.. a Ni:xture of 
Equal Parts 8% iunino Acids Solution and. Dextrose in lvlater 50% 
-----------------------------------"\:------
Zones of Inhibition (mm) 
1 hour I 12 hours 
~~tibiotic in Ster. 
Hater for Injection 
Antibiotic in P~ino 
Acids Solution 
Antibiotic ·in Ste:r. Antibiotic in Amino 
\rJater for Inject~1 on Acids Solution 
27.3 27.0 
27.2 27.9 
27.9 26 .. 7 
27.3 28 .. 1 
27.7 
26.2 
28 .. 3 25 .. 9 
26.3 
27.7 27.5 
27.2 26 .. 2 
27.3 26.8 
27.5 27 .. 9 




















22 .. 2 



















Table 19 .. 
The Inhibition of Gro"t"rth of Staphlococcus aure~ls by 
Pol:yvcillin N at a Concentration of 20 ~g. ml in 
Therapeutic Concentrations of :raectrolytes Admixed to Equal 
Parts 856 .Amino Acids Solut;ion· and Dextrose in vla er 50% 
Zones of Inhibition (mm) 
-112 
1 hour hours 
Antibiotic in Ster. 
Water for Injection 
Antibiotic in Amino 
Acids Solution ·v.rith 
Electrolytes 
Antibiotic in stJr. 
\'later for Injectilon 
Antibiotic in Amino 













27 .. 0 
28 .. 1 






26 .. 8 
27.2 
27.9 
27 .. 8· 
')n /'" 
c...().O 
26 .. 9 
27.6 







































25.00 +0.610 co \..0 
Table 20 
The Inhibition of Growth of Staphlococcus aurev~s by 
Keflin at a Concentration of 50 Ag/ml in a Mixture of 
Equal Parts 896 A.rnino Acids Solution and Dextrose in lvJater 50% 
Zones of Inhibition (mm) 
1 hou~ 12 hours 
Antibiotic in stJir. Antibiotic in Amino 
Water for Injection Acids Solution Antibiotic in SterQ Antibiotic in Amino Water for Injection Acids Solution 
33.2 35.0 35.4 35.8 
34.8 33.9 34.2 34.7 
3'' D ...... 35.6 34.2 35.8 
33.6 35.6 34-.1 35.8 
35 .. 2 33.4 34.6 35.0 
32.6 36.0 33.0 33.8 
3L~.2 31.2 33.9 34.2 
33 .. 4 35.8 35.0 35.2 
35.2 35.0 ·35.8 
31 .. 6 34.4 36.0 34.5 
33.6 35.0 35.4 35.0 
32.8 32.6 3L~.o 35.8 
32 .. 4 33.0 3L~.o 
36.0 3LI-.A 34.1 35.0 
32.7 ,36.0 ~ .2.2& 




The Inhibition of Gro,·rth of Staphlococcus aureti.s by 
Keflin at a Concentration of 50 ,u.g/ml in Thera~~eutic 
Concentrations of Electrolytes ACL.'Ilixed to Equ.al 
Parts 8% Amino Acids Solution and Dextrose in lVa~er 50% 
i 
Zones of Inhibition (mm) 
1 hour 12 hours 
JL~tibiotic in Ster. 
Water for Injection 
34 .. 1 
34 .. 0 













He an 33-37 +2.122 
.A..~tibiotic in Amino 









33 .. 2 
32 .. 8 




3L! .• 7 
36.0 
34.05 +1.156 
Antibiotic in Ste\r. 
















34.90 +0. 117391 
. - ' 
Antibiotic in k'Ilino 

















35.26 +0.696 '.{) 
l-' 
Table 22 ,. 
The Inhibition of Grm~th of Staphlococcus aureu!s by 
Kantre:x at a Concentration of l.J-00 }tg/m1 in a· Mixtju.re of 
Equal Parts 8% .ibnino Acids Solution and Dextrose· in il:later 5076 
Zones of IrJiibition (~~) 
1 hour 12 hours 
Antibiotic in Ster. 
Water for Injection 
Antibiotic in Amino 
Acids Solution 
Antibiotic in Stelr. Antibiotic in Amino 
\!later for Injecti:on Acids Solution 
He an 
15.6 








1? .. 2 
20 .. 0 
17 .. 0 
15.8 














16 .. 6 
19.8 
















17 .. 2 
15.9 



















The Inhibition of Gro'l:rth of Staphlococcus aurev.s by 
Kantrex at a Concentration of 400 Mg/ml in. Therqpeutic 
Concentrations of Electrolytes Admixed to Equal 
Parts 896 Amino Acids Solution and Dextrose in vldter 5096 
Zones of Inhibition (mm) 
1 hour 12 hours 
Antibiotic in Ster. 
\vater for Injection 
Antibiotic in Amino 
Acids Solution "~:Jith 
Electrolytes 






























17 .. 3 
15*9 
17 .. 2 
16.4 































17.20 +0.492 \..0 
\)J 
Table} 24 
The Inhibition of Gro~:Jth of' Stanh1ococcus aure~1s by 
Garamycin at a Concentration of80 ~glm1 in a Hlliure of 
Equal Parts 896 Jlu11ino Acio.s Solution and Dextrose in I \later 50% 
Zones of Inhibition (mm) 
1 hour 12 hours 
Antibiotic in Ster. 
·water for Injection 
Antibiotic in Amino 
Acids Solution 
Antibiotic in stJ;r. Antibiotic in Amino 
I.!Jater for Inject~Lon Acids Solution 
17.2 16.6 16.0 16.4 
15.0 17.0 16.2 16.0 
17.6 17.2 15.4 17.0 
17.7 16.3 15.0 ,16.8 
16.7 17 .. 0 17.3 16.2 
17 .. 4- 16.4· 15.5 17.1 
16.6 16.6 15.3 17.3 
15.3 19 .. 2 14 .. 8 15.8 
15 .. 0 17 .. 1 14.6 16.5 
19 .. 2 16.7 14-.5 16.0 
16.2 17.0 17.4 16.4 
14-.9 16.5 15.9 16.4-
15.7 16 .. 3 17.4 16.0 
19.6 "20 .. 1 15.9 16.2 
14 .. 4- 18 • .2 1;2.2 16 .. 2 




The Inhibition of Grovvth of Stanhlococcus au.ret;ts by 
Garamycin at a Concentration of 80 Bg/ml in Ther.SLpeutic 
Concentrations of Electrolytes Admixed to· Ea~tal 
Parts 896 Amino Aeids Solution. and Dextrose in \•la~:er 5096 
Zones of Inhibition (mm) 
1 hour 12 hours 
PIGibiotic in Ster. 
Water for Injection 
14.8 
15 .. 7 
15.0 
14.9 
lL~ .. l 
14 .. 7 
18.2 
1 'A 0 








Iviean 15.13 +1 .. 07 
Antibiotic in Amino 
Acids Solution vJith 
Electrolytes 
17.2 
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Antibiotic in Amino 






















Calculated Results of "Student t" Evaluation 
Polycillin N in Equal Parts 876 Amino Acids Solution and 
Dextrose in Water 50% 
1 hour 
12 hours 
t = 0.198 
t = 1.490 
( 0. 9 > P<O. 7) 
(0.2->P<O.l) 
df - 38 
df = 43 
PolycilJ.in N in Equal Parts 8% Amino Acids Solution and 
Dextrose in Water 5096 and :Slectrolytes 
Kef1in in Equal Parts 896. Amiri.o Acids Solution and Dextrose 
in \'later 5096 
1 hour 
12 hours 
t = 1.767 
t = 1.332 
(O.l~P<0 .. 05) 
(0.2>P<O.l) 
df = l~2 
df = 42 
Keflin in Equal Parts 896 1\.mino Acids Solution and Dextrose 
in Water 50?6 and Electrol:'"··+;-es 
1 hour 
12 hours 
t = 0.015 
t = 1.932 
(0 r· p· 0 ·z' "/1>. < -· ":J .J (O.l>P<-0 .. 05) df = L~2 df = 1+3 
Kantrex in Equal Parts 896 Amino Acid:;:: Solution and Dextrose 
in \'later 5096 
1 hour 
12 hours 
t = 2.716 
t = 0.995 
(O.Ol>P<O .. OOl) 
(0.5>P<0 .. 3) 
df = Lij 
elf = 42 
Kantrex in Equal :Parts 8]6 Amino Acids Solution and Dextrose 
in \Vater 5696 and Electrol::-'~-~s 
l hour 
12 hour·s 
t = 0.035 
t = 0 .. 860 
(P<:0.9) 
(0.,5>P<0 .. 3) 
df = L~3 
df = '+2 
Garamycin in Equal Parts 896 _1\..rnino Acids Solution and Dextrose 
in Water 50)';.;· 
1 hour 
12 hou.rs 
t = 0.325 
t ""' 3.556 
(Oo9>P<0 .. 7) 
(P<O.OOl) 
a.r == 43 
elf = L!-3 
Garamycin :Ln I·~qual Parts B96 Amino Acids Solution and Dextrose 
i:n \'later 50Jb and EJ.ectroly";es 
1 hour 
12 hours 
t ::: 2 .. 562 
t -· 4 .. B90 
( 0 p O~~:>P<O., 01) 
(~<OoOOl) 
d.f _., 43 




f-1ost often, the pH of parenterals ivill determine 
admixture compatibility. Parker (90) has implied that pH, 
gas content, solvent type, and moisture is carefully con-
trolled in many parenterals. Consequently, when " ••• such 
sensitive drugs are diluted to larger volumes by an aqueous 
solution of a different pH containing atmospheric oxygen 
-\"rhich might catalyze or initiate a reaction, decomposition 
is possible 11 (90). The combination of preparations ivith 
~brerse hycLr.ogen ion content predisposes the miA.'ture to incom-
patibility, \vhether visual or unseen. The apparent physical 
compatibility in these instances should not be construed as 
an indication of chemical compatibility. There exists the 
possibility of degradation products possessing a certain 
degree of solubility before the point of solution saturation 
is surpassed, which \·Jill result in a visual manifestation of 
incompatibility (90) .. 
The amino acids/dextrose solution v1as found to have 
a pH of 6.15. The addition of various levels of electrolytes 
produced slight alteration in this value (Tables 5 to 7). The 
direct admixture of potassium phosphate and calcium gluconate 
in an aqueous medium resulted in immediate precipitation. 
~'his finding coincides vJ'ith a previous study (66). Yet, the 
97 
98 
hyperalimentation solution accommodated elevated levels of 
these electrolytes before particulate matter appeared. Quite 
interestingly, magnesium sulfate seemed unreactive in the 
presence of either electrolyte, contrary to earlier reports 
(64,66;68,91). The reason for this remains unclear. Perhaps 
'the complex nature of the amino acids/dextrose solution pro-
vides physical barriers to possible interaction between the 
electrolyte additives. 
The order of electrolyte admixture VJas determined 
pertinent to the compatibility of elevated concentrations .. 
Potassium phosphate should precede the addition of calcium 
gluconate. This would be in agreement with the findings of 
q?llin, et al. (86). The amino a~ids/dextrose solution vias 
also found to accommodate 100 mEq/L of either electrolyte as 
a single additive without demonstrating physical incompati-
bility. 
The addition of Solu B Forte to the basic stock solu-
tion \vith electrolytes appeared to overtax the buffering 
capacity of the nutrient solution (Table 8). Solu B Forte 
measured a pH of 3.0 prior to admixture. The alteration of 
pH b~y f1VI addition v1as ascertained insignificant (Table 8)., 
Similarly, single admixtures of Folvite, Rubramin PC, and 
Aquamephyton to the hyperalimentation infusate ·with electro-
lytes failed to demonstrate any interaction (Tables 9 and. 10) .. 
Folic acid_, with a pH of 8.0 to 11.0 (92), failed to precipi-
tate in the presence of calcium salts as is reported (93)., 
Rubramin PC did not exhibit visual signs of decomposition 
' 
which is reported to occur in the presence of elevated 
dextrose levels (64,79,93). 
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The examination of the hyperalimentation solution 
containing electrolytes and vitamin combinations also failed 
to manifest evidence of physical incompatibility (Table 11). 
·The literature has reported instances .of decomposition with 
many such mixtures presently formulated for total parenteral 
nutrition~ Ascorbic acid has been implicated in the degrada-
tion of cyanocobalamin (64,79,82,91,94) and phytonadione (64, 
91). The decomposition of cyanocobalamin and phytonadione in 
the presence of each other is also noted (64,79,91,94). Lack 
of physical demonstration of this occurrence enforces the con-
cept that physical compatibility is not necessarily indicative 
of chemical compatibility. 
The addition of Iletin U-40 (Table 12) did not appear 
to alter the pH or compatibility characteristics of the amino 
acids/dextrose solution significantly. T1rJO instances of pre-
cipitation \':Tere noted at the end of the 2L~ hour period of 
observation; ho·,·Jever, the reason for this remains unclear .. 
The addition of various concentrations of potassium 
phosphate and calcium gluconate to the basic stock solution 
prior to antibiotic admixture demonstrated a detrimental effect 
on the compatibility and stability of these agents (Table 15) .. 
Elevated levels of electrolytes caused precipitation in most 
mixtures by the end of 12 hours after admiA~ure. Polycillin N 
appeared to be; the least stable.. Keflin \·Jas observed to be 
the most stable. These data vJould suggest that Polycillin N 
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should not be admixed with other medicaments as previously. 
advised. Keflin has been cited to be incompatible \•Tith . 
calcium gluconate (64,65,94). This 1'1ould appear substantiated 
in the presence of elevated levels of the electrolyte admixed 
to the hyperalimentation solution. Reported interaction of· 
· Kantrex '''ith dextrose (64,91), accompanied with elevated 
concentrations of electrolytes could be implicated ·t,~Tith its 
precipitation in approximately eight hours (Table 15). 
To further challenge the amino acids/dextrose/ 
electrolyte/ru."ltibiotic mixture, supplemental vitamins were 
admixed for observation of possible physical incompatibility 
(Tables 16 and 17). The acidic nature of Solu B Forte appeared 
~~ reduce instances of precipitat~on at elevated electrolyte 
concentrations. Again, Polycillin H appeared the least stable .. 
The utilization of ~NI did not suppress the final pH of the 
mixture as did the Solu B Forte. Consequently, Polycillin N 
stability increased, 'li'lhereas, the stability. of Kant rex; Keflin, 
and Garamycin \'Jas noticeably decreased.. The reported possi-
bility of decreased antibiotic efficacy in the presence of 
riboflavin (65), nor the inactivation of Keflin in the presence 
of Vitamin B-complex and C (64) should not be overlooked. 
As this study vras undertaken to establish the compati-
bility and stability of the solution of amino acids and dextrose 
when mixed I.·Jith commonly employed supplements, compatibility 
bet\•leen these supplemental agents themselves v1as not investi-
gated. As a result, the amino acids/dextrose solution under-
Hent admixtures of each adjunct and was examined by means of 
101 
u.,v. spectroscopy. Where possible, both components \llere 
scanned in the mixture. Signi~icant alterations of the Amax' 
wavelength of absorbance, and/or appearance of new peaks was 
considered suggestive of chemical interaction. 
The u.v. spectrograms obtained for the aliquot dilu-
·tions of the amino acids/dextrose solution reflect the 
phyenlalanine and tryptophan (95,96). ·The most notev10rthy 
alterations of U. V. spectra occurred 't•Thile scanning combina-
tions o~ the hyperal.imentation solution and each of the 
multiple vitamin preparations (Figs. 7 to 13). These spectro-
grams were suggestive of interaction. Parker reports that 
thiamine is readily susceptable to cleavage by sodium bisulfite 
(90). The percentage of decomposition of B1 has been estimated 
to be 10% in 2 hours, and 2576 in 6 hours. The 89~ .Amino Acids 
Solution contains potassium metabisulfite, 100 mg/L, and may 
interact in similar manner v.Ji th the thiamine. 
Unfortunately, the therapeutic levels of Folvite, 
Rubramin PC, and Aquameph;yton 1:Tere too dilute to substantiate 
the various claims regarding their inactivation in the presence 
of each other. This study vms beyond the scope o~ this investi-
gation. 
U.V. spectroscopic examination of antibiotic/amino 
acids/dextrose mixtures proved inconclusive (Figs .. 18 to 22). 
The only altered spectrogram \·ms exhibited by the Polycillin N/ 
amino aci.<1s solution mixture (Fig. 18).. A secondary peak at 
221.1. nm appeared \·Then the solution was scanned one hour after 
admixture. This peak remained unchanged throughout the 12 
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hour period of examination. The addition of Keflin to the 
amino acids/dextrose solution appeared to reflect a ~ypo­
chromic shift in absorbance of the amino acids solution spectra. 
However, detrimental interaction betv1een Keflin and the solu-
tion of amino acids and dextrose vms not suggested by the 
·microbiological assay. 
It should be emphasized that throughout the u.v. spectro-
scopic study, aqueous dilutions were required to provide optimum 
concentrations for scanning. There exists the possibility this 
procedure could have initiated or catalyzed the reactions 
revealed through the altered U.V. spectrograms. 
Thin layer chromatography suggested the possibility of 
chemical reaction upon the addition of electrolytes and vita-
mins to the amino acids solution (Fig. 24). The chromatogram 
produced from a sample 12 hours after its mixture presents 
striking inconsistencies in the amino acids migration pattern~ 
Further study should be undertaken before Solu B Forte is 
rated completely compatible in total parenteral nutrition. The 
pictorial results in Figure 25 lack conclusive evidence sug-
gesting chemical interaction5 Even though some amino acid 
components of the chromatogram are not congruous,- the spatial 
arrangement remains proportional. Due to the complexity of 
the solvent systems, the investigator elected. to retain the 
solvents utilized in the development of the one hour sample 
for the sample withdrm·m 12 hours after admixture. Prepara-
tion of nevi solvents could unnecessarily give rise to new 
variables. 
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Initial examination of the antibiotic/amino. acicls 
solution combinations using U. V. spectrosc6py \•las unremark-
able (Figs. 18 to 22). Subsequent study of these solutions 
by microbiological assay suggested no significant detrimental 
chemical interaction. Btatistical analysis of these results 
(Tables 19 to 26! indicated no significant decrease in anti-
microbial effect between the aqueous controls ana. the test 
sample solutions. The presence of the electrolytes appeared 
to enhance the potency of Garamycin significantly. This 
observation ".-Jill require further investigation. Elevated 
levels of dextrose and electrolytes did not appear to impede 
the activity of the antibiotics significantly as has been 
reported (61+,65,91, 94). Vitamins were not included in the 
mixtures,·as riboflavin is reported to cause rapid degradation 
of these agents (65). It vms also noted that undiluted amino 
acids/dextrose solution, used as a control, exhibited an 
inhibitory effect upon the grm:Jth of the organism utilized. 
'l'hese data \vould suggest that potassium phosphate and 
calcium gluconate do present compatibility problems in levels 
exceed.ing certain therapeutic concentrations.. Their order of 
admixture also determined. the maximum compatible levels. The 
important rolE-) of pH in parenteral admixtures \oJas best exempli-
fied with the addition of multiple vitamin preparations to the 
hyperalimentation solution. Liquid mix:tures which are observed 
as physically compatible may in fact be undergoing chemical 
interaction or degradation. It is recommended that employment 
of Solu B Forte, ar; a routine vitamin ·supplement in total 
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parenteral nutrition, be approached .cautiously until further 
conclusive studies are completed. A study of whether the 
nature of degradation products are possibly detrimental to 
the patient should be paramount. On the other hand, results 
of TLC analysis would suggest that rwr may be better suited· 
'for vitamin supplementation in this hyperalimentation infusate • 
. The remaining vitamins , i.e~ , Fol vi t e, Rubramin PC, and 
Aquamephyton failed to demonstrate physical incompatibility 
upon ad.rnixture, as well as manifest signs of chemical inter-
action \·rith the amino acids solution through U. V. spectroscopic 
analysis. 
Therapeutic levels of antibiotics appear to remain 
stable and efficacious for 12 hours after admixture to the 
hyperalimentation infusate, except in the presence of elevated 
concentrations o.f electrolytes and HVI. 
Chapter 5 
CONCLUSION 
The patient criteria for initiation of total parenteral 
nutrition have been discussed. The nutritional requirements 
for protein administered in combination "~.'lith various supple-
mental agents has been vJell documented. The advantages of 
utilizing a pure protein source, i.e., crystalline or synthetic 
amino acids., \vere described. In order to establish compati-
bility and stability characteristics of a mixture of equal 
P?-rts 896 Amino Acids Solution and .Dextrose in \vater 507'6, the 
solution uncler\'Jent various adrni::-rtures of commonly employed 
electrol;ytes, vitamins, insulin, and selected antibiotics .. 
The nutrient solution appeared to accommodate levels 
of potassium phosphate, calcium gluconate, and mag11esium sul-
fate i·..rell in excess of "usual" therapeutic concentrations. 
Similarly, commonly employed vitamin supplements and insulin 
were examined in combination i:Jith the hyperalimentation solu-. 
tion and failed to demonstrate signs of physical ·incompatibility. 
Howcnrer, instrumental analysis, i.e., U.V .. spectroscopy and 
thin-J.e.yer chromatography, suggested, in fact, there may have 
been chemical interaction of Solu B Forte and NVI once admixed 
vJith the amino acids/dextrose soluti9n. Yet, results of thin-
layer chromatography did not appear to substantiate chemical 
interaction bet"tveen MVI and the amino acids solution.. The 
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investigator contends further study ·Of multiple vitamin 
infusion stability be completed before definite conclusions 
are formulated regarding their compatibility in this nutri-
tional infusate. 
Therapeutic levels of selected antibiotics, i.e., 
Polycillin N, Kantrex, Keflin, and Garamycin, were examined 
separately in combination with the amino acids/dextrose solu-
tion alone, i.·Jith electrolytes, and with electrolytes and vita-
mins. Elevated concentrations of potassium phosphate and 
calcium· gluconate in combination vlith MVI appeared to accelerate 
the signs of physical incompatibility. Subsequently, these 
anti biotic/amino acids solution mb,.rtures were examined uti liz-· 
~~g U.V. spectroscopy. These datq suggest an absence of chemical 
intera.ction. Further information from· a microbiological assay 
-indicated that admixture of antibiotics in these hyperalimenta-
tion solution mixtures did not significantly reduce the anti-





Heird, \v. c., Driscoll, J. N., Schullinger, J. N. et al.: 
Intravenous Alimentation in Pediatric Patients, J: Fed. 
80(3):351-72 (Mar.) 1972. 
11eng, H •. c.: Use of Fat Emulsions in Parenteral Nutrition, 
Drug Intell. Clin. Pharm. 6:321~330 (Sept.) 1972. , 











Dudrick, s. J. and Wilmore, D. H.: Long-Term Parenteral 
Feeding, Hosp. Prac. 2(10):65-78 (Oct.) 1968. 
Klotz, R., Sherman, J. o., and Egan T.: Preparation of 
Hyperalimentation Solutions for Seven Pediatric Patients, 
Amer .. J. Hosp. Ph§.&.. 28:102 (Feb.) 1971. 
Elman, R.: Iv1aintenance of Nitrogen Balance by_ the 
Intravenous Administration of Plasma Proteins and Protein 
Hydrolysates, Ph.,Y.siol .. Rez.!.. 24:372 19Li.l+~ 
Dudrick, S. J.: Total Intravenous l~eed:i.ng and Grm·rth in 
~ppies, Fed .. Proce. Q_:l~81 1966. 
Dudrick, s. J., 1-vilmore, D. i:l., Vars, H .. Me and Rhoao.s, 
J·. E.: Long Term Total Parenteral Nutrition· v1ith GrovJth, 
Development and. Positive Nitrogen Balance, Surg,. 64:13L~. 
(Jul.) 1968. . - -
Wilmore:, D .. vJ. and Dudrick, s .. J .. : Grm·Jth and Development 
o.f an Infant I?.eceiving all. Nutrients Exclusively by Vein, 
J .. A.!M.J;. .. 202_:860 (Nar.) 1968. 
Dudrick, S. F., l:Jilmore? D .. W., Vars, H. f1. ·and Rhoads, 
J. E. : Can Intravenous Feeding as a Sole l··Ieans of · 
Nutrition Support Grm·r:-;h in the Child and Restore Weight 
IJOSS in an Adult? A...'1. Affirmative Answer, Anno BuJ~o 169: 
9?4-8L~ (Jun.) 1969. ---·-- -· ---· 
Flack, H. Lo, Gans, J. A., Serlick, s. E. and Dudrick, 
s. J .. : The Current Status of Parenteral Hyperalimentc-l't;ion~ 
Amer. ~jf.OSTJ._Pharm. 28:326-35 (I"Iay) 1971. 
Du.d.rick, S. J. and Rhoads, J .. E.: New Horizons for 
















Preston, M. J.: Corilparisons of the Various Amino Acid 
Preparations, C1Jn. Pharmaco1. Ther. 9:61 (Jan.--Feb.) 
1968. 
Rea, W. J., w. J., andMcC1elland, R. r1.; et al.: 
Intravenous Hyperosmolar Alimentation, Arch-.-Surg. 
100(4):393 (Apr.) 1970. 
Vlyrich, W. J., Rea, T.tl. J. and McClelland, R. M.: Rare 
Complications with Intravenous Hyperosmotic Alimentation, 
J.A.M.A. 211:1697 (Mar.) 197,0. 
\vi1more, D. Vl. and Dudrick, s. J.: Treatment of Acute 
Renal Failure with Intravenous Essential L-Arnino Acids, 
Arch. Surg. 99(5):669 (Nov.) 1969. 
Elwyn, D. H. and Greenstein, A. J.: A Critique of 
Parenteral Alimentation itJith Respect to Amino Acid 
Metabolism, Gastroenterology ~(3):242-57 (Sept.) 1972. 
Shils, M. E.: Guidelines for Total Parenteral Nutrition, 
J.A.M.A. 220(13):1721 (Jun.) 1972. 
Stegink, L. D. and B.St.ker, G. L •. : Infusion of Protein 
Hydrolysates in the .Nevvborn Infant; Plasma amino acid 
concentrations, J .. Ped. 2.§_(L~):595 (Apr&) 1971.. 
Dryps, J'ohn S. : Hyperalimen.tation Revie'.1, Drug ];;nformat~_gn 
Bull.etin, The Grace Hospital, Detroit, Nichigan, 2(1):1-
13 (:Bleb.) 1972. 
RaviJ.?-, R .. L.: Parenteral _Hyperalimentation, Drug Intell .. 
ClJ.n. Pharm .. 6:186-89 (Nay) 1972. 
Filler, L. J., Jr. , Burness, L. A., Goldbloom, R. B .. , ~t .§.l· : 
Parenteral :F!'eeding-A Note of Caution, Ped. Lf-9:776-9 (T:iay) 
1972. 
Klotz, R.: Reducing Bacterial and Fungal Infection 
Associated with Parenteral Alimentation, Hosn. Phar .. 
2=93-4 (Mar.) 1972. · 
Liebert, P. S .. : Central Venous Catheters in Children-
Their Placement and Care, Cline Ped~. 10(4) :218 (Apr.) 
19?1. 
Shadomy, Smith and Shadomy, H .. ~Jean: 
in Casein Hydrolysate Solution, N. 
(May) 1972. 
Grot·Jths of Candida · 
Eng. J. IvJed. 286:613 
26. \\linters, Ro 1:1~, Santulli, R. V., Heird, H. Ce, et al.: 
Hype::.·alimentation i'Jithout Sepsis, ~· Eng .. J. 'f,I~cl:--286: 













Tachen, M. L. ancl Walther, L. J.: Peripheral Alimentation 
of the. Small Premature Infant·, J. Ped. 80:895 (1'1ay) 19'?2. 
Silvis, s. E. and Paragas, P. D.: Paresthesias, Weakness, 
Seizures and Hypophosphatemia in Patients Receiving 
Hyperalimentation, Gastroenterolog;y 62 ( 4): 513 (Apr.) 
1972. 
Anonymous: Fatal Hyperalimentation Syndrome, Nutr. Rev. 
~0~5):121 (May) 1972. 
Ghadimi, H., Abaci, F., Kumar, s. and Rathi, M.: 
Biochemical Aspects of Intravenous Alimentation, Ped. 
48(6):955 (Dec~) 1971. 
Chan, James c. M., r-1alekzadeh, M .. and Hurley, J.: pH and 
Titratable Acidity of Amino· Acid f·1ixtures-~used in -~--===-:c_~~~ 
Hyperalimentation, J.A.l'-1.A. 220(8).:1119-20 (r1ay) 1972. · 
Chan, James C. M., Asch, M,. J., Lin, S., and Hays, D. H.: 
Hyperalimentation "~dith Amino Acid and Casein Hydrolysate 
Solutions, J.A.M.A. 220(13):1700-5 (Jun.) 1972. 
Karpel, J. T. and Peden, V. H.: Copper Deficiency in 
Long-Term Parenteral Nutrition, ~. Ped. 80_: 32 (Jan.) 
1972. 
Danks; M. D .. , Campbell, P. E., Stevens'· B. J., §t aJ.:..: 
Henke's Kinky Hair Syndrome, Ped. 50(2):188-201 Thug .. ) 
1972 .. 
Ashcraft, K. \'1. and Leape, L. L .. : Candida Sepsis 
Complicating Parenteral Feeding, J.A.fvi.-A. 212:454-6 
(Apre) 1970. 
Travis, S. F., Sugerman, H. J. and Ruberg, R. L.: Red 
Cell fvJetabolic Alterations Induced by Intravenous 
Hyperalimentation, N. Eng. J., iVIed., 282(14):763 (Sept .. ) 
1971. 
Abel, R. l'-1., Abbott, VJ. H. and. J?ischer, J. Eo : Acute 
Renal ]'ailure :'l'reatment without Dialysis b;:,r Total 
_Parenteral Nutrition, Arc~ Sur:& .. 1Q2:513-14· (Oct.) 
1971. 
Peden, V .. H .. , Hitzeben, C .. J~ .. and Skelton, M. A.: Total 
Parenteral Nutrition, J .. Fed._ 2.§(1 )_: 180 (Jun.) 1971. 
He:i.rd, \'1. c., Nicholson, J. Fq Driscoll, J. M., et al.: 
Hyperammonemia H.et>ulting from Alimentation Using a 
Hixture of Synthetic IJ·-Amino Acids: A Preliminary Report, 















Caldwell, M.D., Halder, T. J. and othersen, H. B.: 
Essential Fatty Acid Deficiency in an Infant Receiving 
Prolonged Parenteral Alimentation, J. Ped .. 81(5):894-98 (Nov.) 1972. -
Ulstrom, R. A. and Bro\vn, D. M.: Hypercalcemia as a 
Complication of Parenteral Alimentation, J. Fed. 81: 
419-20 (Aug.) 1972. · ·--
Allison, J. B.: Nitrogen Balance and the Nutrition Value 
of Protein, J.A.M.A. 164:283-89 (May) 1957. 
Kinney, John M.: Calories-Nitrogen-Disease and Injury 
Relationships, Drug Intell. Olin. Pharm. 6:261-65 (Jul.) 
1972. - -
Rice, C. O., Orr, B., Treloar, A. E., et. al_. : Parenteral 
Nutrition in Surgery, Arch. ·Sur~. 61:977-91 (Dec.) 1950. 
Hyman, c. J., Reiter, J., Rodnan, J. and Drash, A. L.: 
Parenteral and Oral Alimentation in the Treatment of 
the Nonspecific Protracted Diarrhea Syndrome of Infancy, 
Js Fed. 1§112:17-29 (Jan.) 1971. 
Mtmro, H,. N.: Basic Conceptf? in the Use of Amino Acids 
and Protein Hydrolysates for Far-enteral Nutritibn, Drug 
Intell. Clin. Pl?...~.!.. 6:216-25 (J-un.) 1972. · 
Dudric:h, S., J.: Spontaneous Closure of Traumatic 
Pancreatoduodenal Fistulas 1:dth Total Intravenous 
Nutrition, J. Trauma 10:542 (Jul.) 1970. 
Hichinar. \'l .. M .. and Lov:, D.: Pa.renteral Nutrition. The 
Age of.the Catheter, Fed. Olin. N .. Amer .. 12.=373 (I"lay) 
1970. 
Sinelair, J .. c., Driscoll, J. M., Heird, \'/.c. and Winters, 
R. i;J. : Supportive Nanagement of the Sick N eo nate: 
11arenteral f'Iaintenance, Ped. Cl:i.n .. N. Amer. 17:878-90 (Nov.) 1970. - --
}'iller, R.. M .. , Burness, IJ. A., Go1dbloom, H .. B., &i al. : 
Total Intravenous Nutrition, .l\ll1§f:.!_ J. S:u_!'g .. 121 :L!·5L4- (Apr.) 
1971. 
Freeman, J. B. and NacLean, L6 D.: Intravenous 
Hypera1imentation:A Reviev1, Can. J. Burg. J.L~:180-9L4-
0·1ay) 1971. 
Benda, G. and Babson, s .. G.: P·eriphera1 Intravenous 
Alimentation of the Small Premature Infant, J. Ped. 
22i22:494 (Sept.) 1971. 
53. 
111 
Dudric~k, s. J. and Ruberg, R. L.: Principles and Practice 
of Parenteral Nutrition, Gastroenterology §.:J-.(6): 901 (Dec.) 
1971. 
54. Peden, v. II. and Karpel, J. T.: Total Parenteral Nutrition 










Driscoll, J. !'1., Heird, \1. C., Schullinger, J. N.,, et §.1. : 
· Total Intravenous Alimentation, J. Ped. 81(12.:145-53 
(Jul.) 1972. - -
Helmuth, W. V., Adam, P. A. J. and Sweet, A. Y.: The 
Effects of Protein Hydrolysate-~1onosaccharide Infusion 
on IJOv.J-birth-weight Infants, J. Fed. 81(1):129-36 (Jul.) 
1972. 
Sauve, Sister Frances: The Pharmacist and a Nutritional 
Intravenous Therapy Program, Amer. J. HosJ2. Phar. 28: 
106 (Feb.) 1971. · · 
Kaminski, M. V.: Total Parenteral Nutrition 
(Hype:calimentation). Prevention and Treatment of 
Complications, Hyperalimentation Registry, \·.Jalter 
Reed General Hospital, Washington, D. c., (Nov.) 1972. 
Guyton, Art1mr c.: Textbook q:f._M?.gicalJ?]:l;y_siolog;y, 3rd 
ed.,, \'1., B. Saunders Co .. , Pililadelphia, Pa., 1966, 
pp. 59-62 .. 
Heinemann, H .. 0.: Acid-Base Balance and Intravenous Fluid 
Therapy' in D-ril;L Is pha£_~~colqgy in, r'1~§-icine., (DiPalma, 
Joseph R. Jtn.), 3rd Bd., HcGraw-Hill Book Co., New York, 
1965' p .. 651+. 
Krupp, r'Iarcus A.: Fluid and Electrolyte Disorders, in 
CJ~~:;s:qE_"t_Di§.e;,gosi£L.£:.:~9: .. J~reatment, Lange fvJ:edical 
'Pllblications, IJo~:; Altos, California, 1972, p. 21. 
Dudr:i.ck, S. J .. : Rational Intravenoue. Therapy, An:f1r. J·. 
1-IOQ.ih_P'Df'J.' .. 28:90 (Feb .. ) 1971. 
Welt, I1. G .. and Blythe, H. B.: Cations: Calcium, Magnesium, 
. Barium, Lithium and. Ammonia, :i.n The __ Pharmacological Be.s~is. 
£U.h..E?~.SJ?eutics, (Goodman, JJ. s. and Gilman, A. Eds:)i.l-th 
Ed., The Nacmillan Co., NevJ York, 1970, PPo 805-lL~. 
Peleisie~e, B.: Guide to Incompatibilities, ~losJ2. Fhar. 
2.: 15-~22 1968 .. 
Fo',,Jler, ~l'. tT .. : Irl.Compatibiliti.es of IV Admixtures, Amer!... 

















Welt, , L. , G. and Blythe, W. B.: Anions: Phosphate, Iodide, 
]'ly.oride, and other anions, in The Pharmacological 
Basis. ~rfpeuti£§., (Goodman, L. s. and Gilman, A. eds.) 
4th Ed., The 'lacmillan Co., New York, 1970, pp. 819-21. 
Swineyard, E. A. and Harvey, s. C.: Gastrointestional 
Drugs, in Rem~ngtQD's Pharm~ceutical Sciences, (Martin, 
E. \·!. ed.) 13th Ed.-;l1ack Publishing Co., Easton, 
Pennsylvania, 1965, p. 881 • 
Al-Rashid, R. A. and Spangler, J.: Neonatal Co:pper 
Deficiency, N. Eng .• J. Hed. 285(15):8LJ·l (Oct.) 1971. 
Graham, George G.: Human Copper Deficiency, N. Eng.~ 
~ ~85(15):857 (Oct.) 1971. , , 
Hospital Formulary, Letterman General Hospital, The 
Presidio, San Francisco, California. 
Fomon, s. J.: Infant Nutrition, W. B. Saunders Co., 
Philadelphia, Pennsylvania, 1967, p. 113. 
Patai, Saul: The Chemi str;y of the A!l}.ino Group, 
Interscience Publishers, London, 1968, Po 561. 
Guyton, op.· cit., p. 1015. 
Jo:O.nson, J .. D$, Albritten, VI. L. and Sunshine, P.: 
Hyperammonemia Accompanying ParEmteral Nutrition in 
Nev1born Infants, i[.!-...P~d!. 81~~).:15'+-61 (J\tl.) 19?2. 
Guyton, op. cit., p. 115 .. 
Edward, Sister ~1ary: pH-An Important Factor in the 
Com:r;a·ljibility of Additives in IV Therapy, Amer.~ 
HO.E.J2.!~):~1.ar.. 24:440 (Aug.) 196?. 
Greene, Ha:cry r~ .. : Vitamins in Parenteral Nutrition, 
D:rgg_ Ir-:.:ttll!_ . .Q1.in:_! ___ fl1a~~ 6:355-60 (Oct.) 1972. 
Burke, \v. A.: Symposium on Total Parenteral Nutrition, 
Food Science Committee, Council on Foods and Nutrition . 
of tho American Nedical Association, Nashville, Tennessee, 
(Jan.) 1972, p. 181. 
Kline~ O. IJ,. and Boehne, J .. vJ .. : Vitamins and Other 
Nub::ients, in :g_~]i:gg:tQg2 P:g_.:~Efll~eey.t:L~:Q...L Practice..§_ 
(Osol, Arthur, Chairman Ed .. Board) 14th Ed., Nack 
Publishing Co., Easton, Pennsylvania, 1970, p. 102L~. 
Ame.r-:L.cap. HQ§J?.:it. al_ Fosm:g.lad'.Y_§ervi~ pub. by Amer. Boc. 
1iosp. Pharm .. , VJashington, D. c., sections 88:08-24 .. 
113 
82. T-!J..e_,r:!grck Inde~, (Stecker, Paul G., Ed.) 8th Ed., Merck 
and Co. Inc., H.ahway, Ne\11. Jersey, 1968, pp. 111.2-5. 
83. Abel, R. M., Abbott, vi. M. and Fischer, J. E.: Intravenous 
Essential L-Amino Acids and Hypertonic Destrose in 
Patients 1/lith Acute Renal :Failure, ~er. J. Surg. 123: 
632-38 (Jun.) 1972. 
84. vleisenfeld, S., Podolsky, S., Goldsmith, L., et al.: 
Adsorption of Insulin to Infusion Bottles and Tubing, 
piab~tes 17:766-71 (Dec.) 1968 • 
. 85. Raf'fanti, E. li'., "Spectrophotomet:r·ic and Microbiological 
Dete:rmination of the Stability of Sodium A.'Tlpicillin as 
affected by pH 11 (unpublished r--Iasters 'rhesis, . University 
-t------------'·~t'~t-11-@-EMi-f-i-~,~19'/-2 )-;-PP--~-J.G-.~---------------
86. Collin, c. F., et. §.}-.• : Precipitation in the Preparation 
of Hyperalimentation Solutions Containing Fre1linine - An 
Electrolyte Study, vlalter Reed Army Institute of Research, 
\valter Reed Army Medical Center, Washington, D. C. 
87. Frye, H. G.: Unpublished Study, through Spencer Laboratory 
Stockton, California. 
88. "The United States Pharmacopeia", 17th rev., Hack 
Publishing Co., Easton, Po.., 1965, p$ 832. 
89. Grove, D.. C. and Randall, VJ. A. : AE?_say ~~th?.£.s _s>:f 
lmtibj:.2:tJ.c.e., Med.ical Encyclopedia, Inc., NevJ York, 
N:~, 1955, PP• 192-94o 
90. Parker.·, Eugene: Solution Additive Chemica]. Incompatibility· 
Study, !~r:1er:_. J. Hosp. PheJ& 2L~:L~3L!--39 (Aug.) 1967. 
91~ Patel, J. and Phillips, G.: A Guide to Physical 
Compatibility of Intravenous Drug Aclmb::tures, Arner. J· .. 
£!.9§.2.!.-~~ g,3..:L!-09-·ll (Aug.) 1966.. -
92 .. Kramer, W .. R.q Inglott, A. s. and Cluxton, R. J .. : 
Ineompatibilities of Drugs for Intravenous Administration, 
in l?.~~§~pe,q~ti_y§s in_QJ1--Ei.9B:l- P}]/:l.J:'I]:laq;z:, (Francke, D. E., and· 
Whitney, J·re, H. A. K. eds.Tlst ed., Drug Intelligenee 
Publications, Hamilton, Ill., 1972, p:p .. 438-55. 
93., Koc:hel, F .. : Incorn.patibilitaten Bei lllischune?;en Int:eavenos(~r 
Losungen, .Bection Des Pharmaciens Des Hospitaux, 
JPecle:ca:tion Interna.tionale Pharmaceutique, Sept. 3-lf.~ 
1968, pp. 57--70, throttgh Persnec~t.:1·v.0.§._ip.__91.:JJd::..9i~l-!lg\I!!~0.SY, 
(Francke, D .. E .. and \'/hitney, J·ro, H. Ae K., eds .. ) 1st Ed,., 
Drug Intelligence Publications, Hamilton, Ill., 19?2, 





I1emburg, H.: Compilation of Pharmaceutical 
Incompatibilities, Hosp. Phar •. 2:19-25 (Aug.) 196? .. 
Rao, G. N. R.: Ultraviolet and Visible Spectroscop~, 
Buttervmrth and Co., Ltd., London, 196?, pp. 190- 2. 
Blackburn, Stanley: Amino Acid Determination, Marcel 
Dekker, Inc., New Y'ork, 1968, p. 182. -
